Processing 00000000.tx.1: Hyperglycemia Promotes Oxidative Stress through Inhibition of Thioredoxin Function by Thioredoxin-interacting Protein* P. 

Phrase: "Hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "Promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "Oxidative Stress through Inhibition of Thioredoxin Function"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   748   C0038435:Stress [Finding]
   748   C0311404:Oxidative [Functional Concept]

Phrase: "by Thioredoxin-interacting Protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "* P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.2: Christian Schulze, Jun Yoshioka, Tomosaburo Takahashi, Zhiheng He, George L. 

Phrase: "Christian Schulze,"

Phrase: "Jun Yoshioka,"

Phrase: "Tomosaburo Takahashi,"

Phrase: "Zhiheng"

Phrase: "He,"

Phrase: "George L."
Processing 00000000.tx.3: King, and Richard T. 

Phrase: "King,"

Phrase: "and"

Phrase: "Richard T."
Processing 00000000.tx.4: Lee From the Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School and Vascular Cell Biology & Complications, Joslin Diabetes Center and Harvard Medical School, Boston, Massachusetts 02139 Received for publication, January 18, 2004 , and in revised form, March 23, 2004.  

Phrase: "Lee From the Cardiovascular Division,"

Phrase: "Department of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "Brigham and Women's Hospital,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C0043210:Women [Population Group]
   812   C1510665:Hospital [Qualitative Concept]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "Harvard Medical School"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "and"

Phrase: "Vascular Cell Biology & Complications,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0009566:Complications [Pathologic Function]
   812   C1171258:complications [Pathologic Function]
   779 E C2362589:Complication [Idea or Concept]
   729 E C0231242:Complicated [Functional Concept]

Phrase: "Joslin Diabetes Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "Massachusetts 02139"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024874:Massachusetts [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "January 18,"

Phrase: "2004 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "March 23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "2004."
Processing 00000000.tx.5: ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Increased intracellular reactive oxygen species (ROS) contribute to vascular disease and pro-atherosclerotic effects of diabetes mellitus may be mediated by oxidative stress. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Increased intracellular reactive oxygen species (ROS)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   804   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C0205332:Reactive [Qualitative Concept]
   804   C1705920:Species [Conceptual Entity]

Phrase: "contribute to vascular disease"
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   833   C0042373:Vascular disease [Disease or Syndrome]
   783 E C0018939:Blood disease NOS [Disease or Syndrome]
   783 E C1533163:Blood disease [Disease or Syndrome]
   770   C0005847:vascular [Body Part, Organ, or Organ Component]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1558950:VASCULAR [Finding]
   770   C1801960:Vascular [Qualitative Concept]
   770   C1880177:Contribute [Activity]
   715 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   715 E C1511228:VESSEL, BLOOD [Tissue]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "pro-atherosclerotic effects of diabetes mellitus"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "mediated by oxidative stress."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0311404:Oxidative [Functional Concept]
Processing 00000000.tx.6: Several ROS-scavenging systems tightly control cellular redox balance; 

Phrase: "Several ROS-scavenging systems tightly"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   762   C0449913:System [Functional Concept]
   762   C1553451:System [Manufactured Object]
   762   C1704459:System [Medical Device]
   712 E C0205373:Systemic [Functional Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "cellular redox balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0014653:Balance [Organism Function]
   827   C0205415:Balance [Functional Concept]
   827   C0560184:Balance [Finding]

Phrase: ";"
Processing 00000000.tx.7: however, their role in hyperglycemia-induced oxidative stress is unclear. 

Phrase: "however,"

Phrase: "their role in hyperglycemia-induced oxidative stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "is"

Phrase: "unclear."
Processing 00000000.tx.8: A ubiquitous antioxidative mechanism for regulating cellular redox balance is thioredoxin, a highly conserved thiol reductase that interacts with an endogenous inhibitor, thioredoxin-interacting protein (Txnip). 

Phrase: "A ubiquitous antioxidative mechanism for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "regulating"

Phrase: "cellular redox balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0014653:Balance [Organism Function]
   827   C0205415:Balance [Functional Concept]
   827   C0560184:Balance [Finding]

Phrase: "is"

Phrase: "thioredoxin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "a highly conserved thiol reductase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "interacts with an endogenous inhibitor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205227:Endogenous [Functional Concept]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "thioredoxin-interacting protein (Txnip)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.9: Here we show that hyperglycemia inhibits thioredoxin ROS-scavenging function through p38 MAPK-mediated induction of Txnip. 

Phrase: "Here"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "thioredoxin ROS-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0205332:Reactive [Qualitative Concept]
   812   C1705920:Species [Conceptual Entity]

Phrase: "scavenging"

Phrase: "function through p38 MAPK-mediated induction of Txnip."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C0815043:function protein [Amino Acid, Peptide, or Protein]
   757   C1527118:Protein Function [Molecular Function]
   739   C0031843:function [Physiologic Function]
   739   C0542341:Function [Functional Concept]
   739   C0700205:FUNCTION [Classification]
   739   C1705273:Function [Intellectual Product]
Processing 00000000.tx.10: Overexpression of Txnip increased oxidative stress, while Txnip gene silencing restored thioredoxin activity in hyperglycemia. 

Phrase: "Overexpression of Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "while"

Phrase: "Txnip gene silencing restored thioredoxin activity in hyperglycemia."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C1325405:thioredoxin activity [Molecular Function]
   757   C1537044:protein activity [Molecular Function]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.11: Diabetic animals exhibited increased vascular expression of Txnip and reduced thioredoxin activity, which normalized with insulin treatment. 

Phrase: "Diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "increased vascular expression of Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "reduced thioredoxin activity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0086439:Reduced Activity [Sign or Symptom]
   901   C1325405:thioredoxin activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "which"

Phrase: "normalized with insulin treatment."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1705169:Treatment [Conceptual Entity]
   770   C1882115:Normalized [Research Activity]
   770   C3538994:TREATMENT [Research Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.12: These results provide evidence for the impairment of a major ROS-scavenging system in hyperglycemia. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence for the impairment of a major ROS-scavenging system"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   751   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in hyperglycemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]
Processing 00000000.tx.13: These studies implicate reduced thioredoxin activity through interaction with Txnip as an important mechanism for vascular oxidative stress in diabetes mellitus.  

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "implicate"

Phrase: "reduced thioredoxin activity through interaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1325405:thioredoxin activity [Molecular Function]
   797   C0086439:Reduced Activity [Sign or Symptom]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "with Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as an important mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "for vascular oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "in diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]
Processing 00000000.tx.14: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Vascular complications such as coronary disease, peripheral artery disease, and stroke are major determinants of morbidity and mortality of patients with diabetes mellitus (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Vascular complications such as coronary disease,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   783   C0544688:complications disease [Pathologic Function]
   753   C0009566:Complications [Pathologic Function]
   753   C1171258:complications [Pathologic Function]
   719 E C2362589:Complication [Idea or Concept]

Phrase: "peripheral artery disease,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C1704436:Peripheral Artery Disease [Disease or Syndrome]
   976 E C0085096:peripheral arterial disease [Disease or Syndrome]
   901   C0489868:Peripheral artery [Body Part, Organ, or Organ Component]
   901   C0852949:artery disease [Disease or Syndrome]
   827   C0003842:Artery [Body Part, Organ, or Organ Component]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205100:Peripheral [Spatial Concept]
   827   C0226004:artery [Body System]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C0221464:Arterial [Spatial Concept]

Phrase: "and"

Phrase: "stroke"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038454:Stroke [Disease or Syndrome]

Phrase: "are"

Phrase: "major determinants of morbidity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1521761:Determinant [Functional Concept]

Phrase: "and"

Phrase: "mortality of patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026565:Mortality [Quantitative Concept]
   790   C0026566:mortality [Quantitative Concept]

Phrase: "with diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: Atherosclerosis accelerates in the diabetic state (13). 

Phrase: "Atherosclerosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004153:Atherosclerosis [Disease or Syndrome]
   928 E C0333482:Atherosclerotic [Functional Concept]

Phrase: "accelerates in the diabetic state"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0241863:DIABETIC [Finding]
   760   C0521110:accelerate [Functional Concept]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C3148680:State [Geographic Area]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.16: Increased formation of reactive oxygen species (ROS)1 contributes to endothelial dysfunction, vessel wall thickening, and lesion formation, thereby playing a crucial role in the progressive deterioration of vascular function and structure (4, 5). 

Phrase: "Increased formation of reactive oxygen species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "(ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "contributes to endothelial dysfunction,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0856169:endothelial dysfunction [Disease or Syndrome]
   770   C0014257:Endothelial [Tissue]
   770   C0031847:dysfunction [Functional Concept]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   770   C1880177:Contribute [Activity]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "vessel wall thickening,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205400:Thickening [Finding]

Phrase: "and"

Phrase: "lesion formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "thereby"

Phrase: "playing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:playing [Daily or Recreational Activity]
  1000   C0600138:playing [Finding]

Phrase: "a crucial role in the progressive deterioration of vascular function"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]
           Functional Role

Phrase: "and"

Phrase: "structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.17: While low levels of ROS participate in important cellular signaling mechanisms (6), increased formation of ROS results in cytotoxic oxidative stress (5). 

Phrase: "While"

Phrase: "low levels of ROS"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "participate in important cellular signaling mechanisms"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0007634:Cellular [Cell]
   753   C0037083:Signaling [Cell Function]
   753   C0178539:Cellular [Functional Concept]
   753   C0441712:Mechanisms [Functional Concept]
   753   C3537152:signaling [Biologic Function]
   719 E C1706376:Mechanism [Manufactured Object]
   719 E C1710082:Signal [Phenomenon or Process]

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "increased formation of ROS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "results in cytotoxic oxidative stress"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   760   C0038435:Stress [Finding]
   760   C0311404:Oxidative [Functional Concept]
   760   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   760   C1274040:Result [Functional Concept]
   760   C1511636:cytotoxic [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.18: Several antioxidative systems tightly regulate cellular redox balance and control formation and reduction of ROS (5, 7, 8). 

Phrase: "Several antioxidative systems tightly"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   779   C0449913:System [Functional Concept]
   779   C1553451:System [Manufactured Object]
   779   C1704459:System [Medical Device]
   729 E C0205373:Systemic [Functional Concept]

Phrase: "regulate"

Phrase: "cellular redox balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0014653:Balance [Organism Function]
   827   C0205415:Balance [Functional Concept]
   827   C0560184:Balance [Finding]

Phrase: "and"

Phrase: "control formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "reduction of ROS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.19: Previously, oxidative stress in diabetes mellitus has been linked to enhanced production of superoxide anion by mitochondria (9) and through protein kinase C-dependent activation of membranous NADPH oxidase (10). 

Phrase: "Previously,"

Phrase: "oxidative stress in diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   760   C0038435:Stress [Finding]
   760   C0311404:Oxidative [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "linked to enhanced production of superoxide anion"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0038836:Superoxide Anion [Element, Ion, or Isotope]
           Superoxide
   748   C0003075:Anion [Element, Ion, or Isotope]
   748   C0033268:production [Occupational Activity]
   748   C2349975:Enhanced [Activity]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "by mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "(9"

Phrase: ")"

Phrase: "and through protein kinase C-dependent activation of membranous NADPH oxidase"
Meta Candidates (Total=24; Excluded=1; Pruned=0; Remaining=23)
   792   C3546691:protein kinase C activation [Molecular Function]
   775   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   772 E C1259877:kinase c protein [Amino Acid, Peptide, or Protein,Enzyme]
   772   C1819041:protein kinase activation [Cell Function]
   756   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0068355:NADPH Oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1151146:NADPH oxidase [Molecular Function]
   754   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   754   C0599177:protein activation [Genetic Function]
   754   C1168438:Protein C [Laboratory Procedure]
   754   C1418943:PROTEIN C [Gene or Genome]
   754   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0025255:Membranous [Tissue]
   738   C0027303:NADPH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0205287:Membranous [Qualitative Concept]
   738   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0851827:Dependent [Qualitative Concept]
   738   C1515981:And [Idea or Concept]
   738   C1701901:Dependent [Qualitative Concept]
   738   C1879547:Activation [Activity]
   738   C3244310:dependent [Functional Concept]
   712   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.20: However, the intracellular redox balance is maintained by ROS-scavenging systems, and the two major intracellular thiol-reducing mechanisms are the interacting glutathione and thioredoxin systems (8, 11, 12). 

Phrase: "However,"

Phrase: "the intracellular redox balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0014653:Balance [Organism Function]
   827   C0205415:Balance [Functional Concept]
   827   C0560184:Balance [Finding]

Phrase: "is"

Phrase: "maintained by ROS-scavenging systems,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   814   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0205332:Reactive [Qualitative Concept]
   748   C1314677:Maintained [Functional Concept]
   748   C1705920:Species [Conceptual Entity]
   714 E C0024501:Maintain [Activity]
   714   C0449913:System [Functional Concept]
   714   C1553451:System [Manufactured Object]
   714   C1704459:System [Medical Device]

Phrase: "and"

Phrase: "the two major intracellular thiol-reducing mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0441712:Mechanisms [Functional Concept]
   766 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "the interacting glutathione"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "thioredoxin systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "(8,"

Phrase: "11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.21: Thioredoxin reduces ROS through reversible oxidation of thioredoxin at two cysteine residues (Cys-32 and Cys-35); 

Phrase: "Thioredoxin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "reduces"

Phrase: "ROS through reversible oxidation of thioredoxin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   800   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   744   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0205332:Reactive [Qualitative Concept]
   744   C1705920:Species [Conceptual Entity]

Phrase: "at two cysteine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "(Cys-32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Cys-35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.22: thioredoxin is then reduced by thioredoxin reductase and NAPDH (11). 

Phrase: "thioredoxin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "is"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "reduced by thioredoxin reductase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0039941:Thioredoxin Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0392756:Reduced [Qualitative Concept]
   770   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "NAPDH"

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.23: Thioredoxin-interacting protein (Txnip), the endogenous inhibitor of thioredoxin also known as vitamin D3 up-regulated protein-1 (VDUP-1) (13, 14) or thioredoxin-binding protein-2 (TBP-2) (15), inhibits thioredoxin antioxidative function by binding to its redox-active cysteine residues (15, 16). 

Phrase: "Thioredoxin-interacting protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "the endogenous inhibitor of thioredoxin also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205227:Endogenous [Functional Concept]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "known as vitamin D3 up-regulated protein-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0008318:Vitamin D 3 [Pharmacologic Substance,Steroid,Vitamin]
   770   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C3265062:vitamin D3 [Pharmacologic Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]
   744   C0205309:Known [Qualitative Concept]
   744   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "(VDUP-1"

Phrase: ")"

Phrase: "(13,"

Phrase: "14"

Phrase: ")"

Phrase: "or"

Phrase: "thioredoxin-binding protein-2 (TBP-2)"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
  1000   C1424661:THIOREDOXIN-BINDING PROTEIN 2 [Gene or Genome]
  1000   C1450344:thioredoxin-binding protein-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1425073:Thioredoxin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1456398:THIOREDOXIN 2 [Gene or Genome]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "thioredoxin antioxidative function by binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "to its redox-active cysteine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "(15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.24: We show here the inhibition of the thioredoxin ROS-scavenging system through induction of Txnip in hyperglycemia. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "the inhibition of the thioredoxin ROS-scavenging system"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0034750:Reactive Inhibition [Individual Behavior]
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C1628982:% inhibition [Quantitative Concept]
   739   C3463820:Inhibition [Activity]

Phrase: "through induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in hyperglycemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]
Processing 00000000.tx.25: In contrast to previous reports describing an increased formation of reactive oxygen species in hyperglycemia, our study demonstrates the functional inhibition of a major cytoplasmic antioxidant system in hyperglycemia. 

Phrase: "In contrast to previous reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "describing"

Phrase: "an increased formation of reactive oxygen species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "in hyperglycemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "demonstrates"

Phrase: "the functional inhibition of a major cytoplasmic antioxidant system"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "in hyperglycemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]
Processing 00000000.tx.26: Moreover, the inhibition of thioredoxin function in hyperglycemia through increased interaction with its inhibitor Txnip forms the molecular basis of increased levels of the freely diffusible molecule hydrogen peroxide contributing to oxidative stress. 

Phrase: "Moreover,"

Phrase: "the inhibition of thioredoxin function"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0021469:Inhibition, function [Molecular Function]
           Inhibition
   760   C0021467:Inhibition [Mental Process]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "in hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "through increased interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704675:Interaction [Functional Concept]

Phrase: "with its inhibitor Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "the molecular basis of increased levels of the freely diffusible molecule hydrogen peroxide contributing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1853126:MOLECULAR BASIS [Idea or Concept]
   734   C1527178:Basis [Functional Concept]
   734   C1874451:Basis [Pharmacologic Substance]

Phrase: "to oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.27: This molecular interaction might play a central role in increasing levels of reactive oxygen species by reduced flow through the enzymatic pathways of ROS scavenging.  

Phrase: "This molecular interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1167622:Molecular Interaction [Molecular Function]
   861   C1704675:Interaction [Functional Concept]

Phrase: "might"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a central role in increasing levels of reactive oxygen species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "by reduced flow through"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "the enzymatic pathways of ROS scavenging."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1704259:Pathways [Molecular Function]
   744   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.28: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Cell CultureHuman aortic smooth muscle cells (SMCs) were isolated from surgical specimens and cultured in Dulbecco's modified essential medium with 10% fetal calf serum. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell CultureHuman aortic smooth muscle cells (SMCs)"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   876   C0596981:cell muscle [Cell]
           Muscle Cells
   861   C1135918:Smooth Muscle Cells [Cell]
   827   C1267092:Muscle, Smooth [Tissue]
   799   C0003483:Aortic [Body Part, Organ, or Organ Component]
   799   C0007634:Cells [Cell]
   799   C0026845:Muscle [Tissue]
   799   C0205357:Smooth [Qualitative Concept]
   799   C3282337:Cells [Cell]
   727 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "isolated from surgical specimens"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   816   C1647891:Surgical specimen [Substance]
   770   C0205409:Isolated [Functional Concept]
   770   C0370003:specimens [Substance]
   770   C0543467:Surgical [Health Care Activity]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   737 E C2347026:Specimen [Conceptual Entity]

Phrase: "and"

Phrase: "cultured in Dulbecco's modified essential medium"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   767   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0009458:Medium [Intellectual Product]
   753   C0205224:Essential [Qualitative Concept]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "with 10% fetal calf serum."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]
Processing 00000000.tx.29: Cells were starved for 48 h in insulin-transferrin medium prior to experiments. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "starved for 48 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C2348531:Starve [Activity]

Phrase: "in insulin-transferrin medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "prior to experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.30: Stimulation experiments were performed using glucose (Sigma), insulin (100 nM, Sigma), insulin-like growth factor-1 (IGF-1) (100 ng/ml, Upstate Biotechnology), PDGF-BB (4 ng/ml, Upstate Biotechnology). 

Phrase: "Stimulation experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(100 nM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "insulin-like growth factor-1 (IGF-1)"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(100 ng/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439275:ng/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "Upstate Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: ")"

Phrase: ","

Phrase: "PDGF-BB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0246681:PDGF-BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0004739:BB [Geographic Area]
   861   C0032200:PDGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332297:BB [Spatial Concept]

Phrase: "(4 ng/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439275:ng/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "Upstate Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.31: The following inhibitors were used: wortmannin (100 nM, Sigma), PD169316 (100 nM, Calbiochem), U0126 (10 M, Calbiochem), GF109203X (5 M, Calbiochem), and pertussis toxin (500 ng/ml, Sigma). 

Phrase: "The following inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "wortmannin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "(100 nM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "PD169316"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0914485:PD169316 [Organic Chemical]

Phrase: "(100 nM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "Calbiochem"

Phrase: ")"

Phrase: ","

Phrase: "U0126"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: "(10 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Calbiochem"

Phrase: ")"

Phrase: ","

Phrase: "GF109203X"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0119104:GF109203X [Organic Chemical,Pharmacologic Substance]

Phrase: "(5 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Calbiochem"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "pertussis toxin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: "(500 ng/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439275:ng/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.32: Northern and Western AnalysesFor the detection of mRNA transcripts by Northern analysis, specific cDNA probes were synthesized using the following oligonucleotides: thioredoxin, 5'-AGCAGCCAAGATGGTGAAGCAGA-3' and 5'-GCTCCAGAAAATTCACCCACC-3'; 

Phrase: "Northern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709269:Northern [Spatial Concept]

Phrase: "and"

Phrase: "Western AnalysesFor"

Phrase: "the detection of mRNA transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "by Northern analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "specific cDNA probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0007512:cDNA Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0182400:Probes [Medical Device]
   793 E C1704681:Probe [Gene or Genome]
   793 E C2347609:Probe [Chemical Viewed Functionally]
   793 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "thioredoxin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "5'-AGCAGCCAAGATGGTGAAGCAGA-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-GCTCCAGAAAATTCACCCACC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.33: Txnip, 5'-TCTGCCAAAAAGGAGAAGAAAG-3' and 5'-GGCGTACATAAAGATAGGGCTG-3'. 

Phrase: "Txnip,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "5'-TCTGCCAAAAAGGAGAAGAAAG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-GGCGTACATAAAGATAGGGCTG-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.34: Total RNA was isolated and loaded to a 1% agarose formaldehyde gel. 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "loaded to a 1% agarose formaldehyde gel."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   774   C1706746:Agarose Gel [Research Device]
   748   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0036681:Agarose [Carbohydrate]
   748   C1382104:Gel [Substance]
   748   C1708715:Loaded [Activity]
   714 E C1550025:Load [Idea or Concept]
   714 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.35: After transfer, the membranes were incubated with radioactive labeled probes, and specific binding was visualized with autoradiography. 

Phrase: "After transfer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040671:Transfer [Mental Process]
  1000   C1705822:Transfer [Activity]

Phrase: "the membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated with radioactive labeled probes,"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   790   C2986808:Radioactive Label [Indicator, Reagent, or Diagnostic Aid]
   760   C0034553:radioactive [Natural Phenomenon or Process]
   760   C0182400:Probes [Medical Device]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1708632:Labeled [Qualitative Concept]
   726 E C0181496:Label [Manufactured Object]
   726 E C1704681:Probe [Gene or Genome]
   726 E C2347609:Probe [Chemical Viewed Functionally]
   726 E C2827499:Label [Governmental or Regulatory Activity]
   726 E C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "specific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205369:Specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1552740:specific [Intellectual Product]

Phrase: "was"

Phrase: "visualized with autoradiography."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004400:Autoradiography [Laboratory Procedure]
   790   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.36: Western analysis was performed using a specific monoclonal anti-Txnip antibody that was raised against full-length human Txnip. 

Phrase: "Western analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a specific monoclonal anti-Txnip antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   893   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   877   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "was"

Phrase: "raised against full-length human Txnip."
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   833   C1450344:thioredoxin interacting protein, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   793   C1504637:thioredoxin protein, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Human Thioredoxin
           Thioredoxin
   767   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767 E C1514764:Thioredoxin (human) [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
           Thioredoxin
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0086418:Human [Human]
   744   C0442818:Raised [Quantitative Concept]
   744   C0443225:Full [Qualitative Concept]
   744   C1444754:Length [Quantitative Concept]
   744   C1706316:LENGTH [Research Activity]
   744   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.37: Thioredoxin was detected by a monoclonal anti-thioredoxin antibody (Medical Biological Laboratories International). 

Phrase: "Thioredoxin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "detected by a monoclonal anti-thioredoxin antibody"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0442726:Detected [Finding]
   748   C0746619:monoclonal [Finding]
   748   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(Medical Biological Laboratories"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   896   C1552406:Medical Laboratory [Intellectual Product]
   896   C3242770:Medical Laboratory [Health Care Related Organization,Manufactured Object]
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: "International"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.38: After incubation with horseradish peroxidase-conjugated secondary antibody, specific bands were visualized by enzymatic chemiluminescence reaction (PerkinElmer Life Sciences). 

Phrase: "After incubation"

Phrase: "with horseradish peroxidase-conjugated secondary antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "specific bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "visualized by enzymatic chemiluminescence reaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C1511131:Enzymatic Reaction [Molecular Function]
   760   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   760   C0234621:Visualized [Functional Concept]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1450278:Chemiluminescence [Natural Phenomenon or Process]

Phrase: "(PerkinElmer Life Sciences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0005526:Life Sciences [Occupation or Discipline]
   827   C0036397:Sciences [Occupation or Discipline]
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: ")."
Processing 00000000.tx.39: Total Akt, phospho-Akt, total p38 MAPK, and phospho-p38 MAPK were detected using specific antibodies (Cell Signaling). 

Phrase: "Total Akt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "phospho-Akt,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0812228:AKT [Gene or Genome]

Phrase: "total p38 MAPK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1120843:MAPK, p38 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "phospho-p38 MAPK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1120843:MAPK, p38 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "specific antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Cell Signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037083:Cell Signaling [Cell Function]
           Signaling
   861   C3537152:signaling [Biologic Function]

Phrase: ")."
Processing 00000000.tx.40: Real Time PCRTxnip gene expression was analyzed by real time PCR (LightCycler, Roche Applied Science) using specific oligonucleotides: human Txnip, 5'-TGGTGGATGTCAATACCCCT-3' (sense) and 5'-ATTGGCAAGGTAAGTGTGGC-3' (antisense); 

Phrase: "Real Time PCRTxnip gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0017262:Gene Expression [Genetic Function]
   804   C0017337:Gene [Gene or Genome]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "analyzed by real time PCR (LightCycler,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   790   C1550177:Real Time [Idea or Concept]
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0040223:Time [Temporal Concept]
   753   C0237400:Real [Qualitative Concept]
   753   C0677874:pCR [Finding]
   753   C0936012:Analyzed [Research Activity]
   753   C3272377:REAL [Intellectual Product]
   753   C3541383:Time [Temporal Concept]

Phrase: "Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0681834:Applied Science [Research Activity]
   827   C0036397:Science [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "specific oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "human Txnip,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1450344:thioredoxin interacting protein, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   923   C1504637:thioredoxin protein, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "5'-TGGTGGATGTCAATACCCCT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ")"

Phrase: "and"

Phrase: "5'-ATTGGCAAGGTAAGTGTGGC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(antisense"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.41: human -tubulin, 5'-TCTGTTCGCTCAGGTCCTTT-3' (sense) and 5'-TTCATGATGCGATCAGGGTA-3' (antisense); 

Phrase: "human -tubulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "5'-TCTGTTCGCTCAGGTCCTTT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ")"

Phrase: "and"

Phrase: "5'-TTCATGATGCGATCAGGGTA-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(antisense"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.42: rat Txnip, 5'-CAAGTTCGGCTTTGAGCTTC-3' (sense) and 5'-GCCATTGGCAAGGTAAGTGT-3' (antisense); 

Phrase: "rat Txnip,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1529751:thioredoxin-interacting protein, rat [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   902   C1335665:Rat Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "5'-CAAGTTCGGCTTTGAGCTTC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ")"

Phrase: "and"

Phrase: "5'-GCCATTGGCAAGGTAAGTGT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(antisense"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.43: rat -tubulin, 5'-CATCCAGGAGCTCTTCAAGC-3' (sense) and 5'-CGCCTTAGGCCTCTTCTTCT-3' (antisense); 

Phrase: "rat -tubulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "5'-CATCCAGGAGCTCTTCAAGC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ")"

Phrase: "and"

Phrase: "5'-CGCCTTAGGCCTCTTCTTCT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(antisense"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.44: human thioredoxin, 5'-AGCAGCCAAGATGGTGAAGCAGA-3 (sense) and 5'-GCTCCAGAAAATTCACCCACC-3' (antisense); 

Phrase: "human thioredoxin,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1504637:Human Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Thioredoxin
   861   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "5'-AGCAGCCAAGATGGTGAAGCAGA-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ")"

Phrase: "and"

Phrase: "5'-GCTCCAGAAAATTCACCCACC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(antisense"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.45: rat thioredoxin, 5'-GCTGATCGAGAGCAAGGAAG-3 (sense) and 5'-TCAAGGAACACCACATTGGA-3' (antisense). 

Phrase: "rat thioredoxin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "5'-GCTGATCGAGAGCAAGGAAG-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ")"

Phrase: "and"

Phrase: "5'-TCAAGGAACACCACATTGGA-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(antisense"

Phrase: ")."
Processing 00000000.tx.46: Adenoviral Vectors for Gene TransferAdenoviral vectors for overexpression of TRX (AdTRX) and Txnip (AdTxnip) were used as described elsewhere (14). 

Phrase: "Adenoviral Vectors for Gene TransferAdenoviral vectors"

Phrase: "for overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]

Phrase: "of TRX"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1336690:TRX [Gene or Genome]
  1000   C1504637:Trx [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1540172:TRX [Gene or Genome]
  1000   C1710337:TRX [Gene or Genome]

Phrase: "(AdTRX"

Phrase: ")"

Phrase: "and"

Phrase: "Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(AdTxnip"

Phrase: ")"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "elsewhere"

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.47: Gene Silencing by Small Interfering RNA (RNAi)Double-stranded RNAi (Qiagen) for selective silencing of Txnip (rACAGACUUCGGAGUACCUGdTT) was transfected into cells (FuGENE Reagent, Roche Applied Science). 

Phrase: "Gene Silencing by Small Interfering RNA (RNAi"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1523523:gene silencing by RNA [Genetic Function]
   778   C0598496:Gene Silencing [Genetic Function]
   774   C1136031:RNA Silencing [Genetic Function]
   748   C0017337:Gene [Gene or Genome]
   714   C0858952:silence [Mental or Behavioral Dysfunction]

Phrase: ")"

Phrase: "Double-stranded RNAi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1136031:RNAi [Genetic Function]

Phrase: "(Qiagen"

Phrase: ")"

Phrase: "for selective silencing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0858952:silence [Mental or Behavioral Dysfunction]

Phrase: "of Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(rACAGACUUCGGAGUACCUGdTT"

Phrase: ")"

Phrase: "was"

Phrase: "transfected into cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "(FuGENE Reagent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0681834:Applied Science [Research Activity]
   827   C0036397:Science [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: ")."
Processing 00000000.tx.48: After transfection, cells were incubated with glucose for Txnip expression. 

Phrase: "After transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for Txnip expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1171362:protein expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
Processing 00000000.tx.49: Scrambled RNAi was used as control. 

Phrase: "Scrambled RNAi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1136031:RNAi [Genetic Function]

Phrase: "was"

Phrase: "used as control."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1273517:used [Finding]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.50: Measurement of Oxidative StressCells were incubated with 2',7'-dichlorodihydrofluorecein diacetate (DCFDA) for 45 min, washed in phosphate-buffered saline, and fluorescence intensity measured using a fluorometer (PerkinElmer Life Science) at 595 nm. 

Phrase: "Measurement of Oxidative StressCells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242485:Measurement [Functional Concept]

Phrase: "were"

Phrase: "incubated with 2',"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "7'-dichlorodihydrofluorecein diacetate (DCFDA) for 45 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0369114:Diacetate [Organic Chemical]

Phrase: "washed in phosphate-buffered saline,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1548982:Washed [Idea or Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "fluorescence intensity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0522510:Intensity [Qualitative Concept]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a fluorometer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0180919:FLUOROMETER [Medical Device]

Phrase: "(PerkinElmer Life Science"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0005526:Science, Life [Occupation or Discipline]
   827   C0036397:Science [Occupation or Discipline]
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: ")"

Phrase: "at 595 nm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.51: Tissue levels of ROS were detected on frozen sections by incubation with dihydroethidium bromide (DHE) for 30 min at 37 C followed by fluorescence microscopy. 

Phrase: "Tissue levels of ROS"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0040300:Tissue [Tissue]
   753   C0441889:Levels [Qualitative Concept]
   753   C1547928:Tissue [Intellectual Product]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "detected on frozen sections"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0016741:Frozen Sections [Tissue]
   799 E C0085188:Frozen Section [Laboratory Procedure]
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0442726:Detected [Finding]
   770   C0677542:Frozen [Functional Concept]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737   C0205155:Section [Spatial Concept]
   737   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   737   C1522472:Section [Substance]
   737   C1552923:Section [Quantitative Concept]
   737   C1705191:Section [Physical Object]

Phrase: "by incubation"

Phrase: "with dihydroethidium bromide (DHE)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006222:Bromide [Inorganic Chemical]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 37 C"

Phrase: "followed by fluorescence microscopy."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0016315:Fluorescence [Natural Phenomenon or Process]
   770   C0026018:Microscopy [Laboratory Procedure]
   737 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.52: Thioredoxin Activity AssayThioredoxin activity was measured using the insulin disulfide reduction assay as described elsewhere (11). 

Phrase: "Thioredoxin Activity AssayThioredoxin activity"

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the insulin disulfide reduction assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "elsewhere"

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.53: In brief, 50 g of cellular protein extracts were incubated at 37 C for 15 min with activation buffer to reduce thioredoxin. 

Phrase: "In brief, 50 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "of cellular protein extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "incubated at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "with activation buffer to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "reduce"

Phrase: "thioredoxin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.54: After addition of reaction buffer, the reaction was started with 5 l of bovine thioredoxin reductase (American Diagnostica Inc., Greenwich, CT) or 5 l of water to controls and samples incubated for 20 min at 37 C. 

Phrase: "After addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of reaction buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "started with 5 l of bovine thioredoxin reductase"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0039941:Thioredoxin Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0007452:Bovine [Mammal]
   744   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1140701:bovine [Mammal]
   744   C1272689:Started [Qualitative Concept]
   744   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   711 E C0439659:Start [Temporal Concept]

Phrase: "(American Diagnostica Inc.,"

Phrase: "Greenwich,"

Phrase: "CT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540513:CT [Gene or Genome]

Phrase: "or"

Phrase: "5 l of water"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C2348935:.5 L [Quantitative Concept]

Phrase: "to controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "incubated for 20 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37 C."
Processing 00000000.tx.55: The reaction was terminated by adding 250 l of stopping buffer followed by absorption measurement at 412 nm. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "terminated by adding 250 l of stopping buffer"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0723457:stopping [Inorganic Chemical,Pharmacologic Substance]
   744   C1553404:terminated [Idea or Concept]
   744   C2348570:Terminated [Functional Concept]
   711   C1883712:Add [Functional Concept]
   711 E C1947925:Stop [Activity]
   711 E C2746065:Stop [Temporal Concept]

Phrase: "followed by absorption measurement"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0000854:Absorption [Natural Phenomenon or Process]
   770   C0220777:absorption [Functional Concept]
   770   C0242485:Measurement [Functional Concept]
   770   C2347023:Absorption [Phenomenon or Process]
   770   C2347080:Absorption [Phenomenon or Process]
   770   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   770   C2825050:Absorption [Phenomenon or Process]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "at 412 nm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.56: In Vivo Model of Diabetes MellitusStreptozotocin (STZ, 60 mg/kg) was injected intraperitoneally in adult Sprague-Dawley rats. 

Phrase: "In Vivo Model of Diabetes MellitusStreptozotocin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1515657:In Vivo Model [Research Activity]
   753   C3161035:Model [Intellectual Product]

Phrase: "(STZ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038432:STZ [Antibiotic,Carbohydrate]
  1000   C1539862:STZ [Gene or Genome]

Phrase: "60 mg/kg"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0439272:mg kg [Quantitative Concept]
   827   C0022718:KG [Geographic Area]
   827   C0439209:kg [Quantitative Concept]
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intraperitoneally in adult Sprague-Dawley rats."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0034715:Rats, Sprague-Dawley [Mammal]
   790   C2699239:Sprague-Dawley [Mammal]
   753   C0001675:Adult [Age Group]
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C1706450:Adult [Human]
Processing 00000000.tx.57: The animals were either sacrificed 4 weeks after injection of STZ or treated with insulin (10 IU/kg/day, subcutaneously). 

Phrase: "The animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "either"

Phrase: "sacrificed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0681205:Sacrifice [Idea or Concept]

Phrase: "4 weeks after injection of STZ"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1442465:4 Weeks [Temporal Concept]
   753   C0439230:weeks [Temporal Concept]
   719 E C0332174:/week [Temporal Concept]

Phrase: "or"

Phrase: "treated with insulin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(10 IU/kg/day,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0439465:IU/day [Quantitative Concept]
   861   C0439418:kg/day [Quantitative Concept]
   812   C0332173:/day [Temporal Concept]
   812   C0439228:day [Temporal Concept]
   812   C0439505:/day [Temporal Concept]

Phrase: "subcutaneously"

Phrase: ")."
Processing 00000000.tx.58: Vehicle-injected animals served as controls. 

Phrase: "Vehicle-injected animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "served as controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.59: Vascular tissues were isolated from the aorta of the animals. 

Phrase: "Vascular tissues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   955   C1511228:Blood Vessel Tissue [Tissue]
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "isolated from the aorta of the animals."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0003062:Animals [Animal]
   748   C0003483:Aorta [Body Part, Organ, or Organ Component]
   748   C0205409:Isolated [Functional Concept]
   748   C1278934:Aorta [Body Part, Organ, or Organ Component]
   748   C1548221:Isolated [Idea or Concept]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.60: All experimental procedures complied with the rules and regulations of the Committee on Ethics and Animal Research at the Joslin Diabetes Center. 

Phrase: "All experimental procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "complied with the rules"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0870077:Rules [Intellectual Product]
   737   C0725694:comply [Food]
   737 E C0805874:Rule [Idea or Concept]
   737 E C1446409:rule [Qualitative Concept]

Phrase: "and"

Phrase: "regulations of the Committee"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0220905:regulations [Regulation or Law]
   770   C0851285:Regulations [Governmental or Regulatory Activity]
   737 E C1327622:Regulation [Biologic Function]

Phrase: "on Ethics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015000:Ethics [Idea or Concept]
  1000   C1527243:ethics [Idea or Concept]

Phrase: "and"

Phrase: "Animal Research at the Joslin Diabetes Center."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0003048:Animal Research [Research Activity]
   774   C0683939:center research [Manufactured Object,Organization]
   748   C0035168:research [Research Activity]
   748   C0242481:Research [Research Activity]
Processing 00000000.tx.61: HistologyThioredoxin and Txnip were immunohistochemically detected by incubation with primary antibody (1:200) followed by incubation with biotinylated secondary antibody (1:200). 

Phrase: "HistologyThioredoxin"

Phrase: "and"

Phrase: "Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "immunohistochemically"

Phrase: "detected by incubation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "with primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ")"

Phrase: "followed by incubation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with biotinylated secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ")."
Processing 00000000.tx.62: Specific binding was visualized by diaminobenzoate. 

Phrase: "Specific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205369:Specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1552740:specific [Intellectual Product]

Phrase: "was"

Phrase: "visualized by diaminobenzoate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.63: Statistical AnalysisAll in vitro experiments were performed at least three times and data are expressed as mean  s.d. 

Phrase: "Statistical AnalysisAll in vitro experiments"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   840   C0021135:In Vitro [Intellectual Product]
   840   C1533691:in vitro [Qualitative Concept]
           vitro
   840   C2827718:In Vitro [Functional Concept]
   804   C0681814:Experiments [Research Activity]
   771 E C1706386:Experiment [Conceptual Entity]
   721 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed at least three times"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C0884358:Performed [Functional Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C2947996:Perform [Pharmacologic Substance]
   726 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as mean  s.d."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0444504:Mean [Quantitative Concept]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.64: The data were analyzed by Student's t test. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed by Student's t test."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0022885:Test [Laboratory Procedure]
   760   C0038492:student [Professional or Occupational Group]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C0936012:Analyzed [Research Activity]
   760   C1551041:student [Idea or Concept]
   760   C1552573:student [Intellectual Product]
Processing 00000000.tx.65: One-way analysis of variance with post hoc analysis was used for the analysis of data sets of more than two groups. p < 0.05 was considered statistically significant.  

Phrase: "One-way analysis of variance"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1709320:One-way Analysis of Variance [Quantitative Concept]
   862   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "with post hoc analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "used for the analysis of data sets of more"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   764   C0150098:data sets [Intellectual Product]
   762   C0010992:Data Analysis [Occupational Activity]
   745   C1524063:Use of [Functional Concept]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0036849:Set [Mental Process]
   742   C0936012:Analysis [Research Activity]
   742   C1273517:used [Finding]
   742   C1442518:Set [Functional Concept]
   742   C1511726:Data [Idea or Concept]
   742   C1524024:analysis [Functional Concept]
   742   C1705195:Set [Conceptual Entity]
   742   C3245479:data [Medical Device]
   708 E C0042153:use [Functional Concept]
   708 E C0457083:Use [Functional Concept]
   708 E C1947944:Use [Intellectual Product]

Phrase: "than two groups. p < 0.05"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   840   C0441849:Group P [Intellectual Product]
   804   C0205448:Two [Quantitative Concept]
   804   C0441833:Group [Idea or Concept]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1552839:groups [Idea or Concept]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "statistically significant."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.66: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Induction of Txnip in Hyperglycemia Enhances Oxidative StressSince increased oxidative stress contributes to the development of vascular complications in diabetes, we investigated the regulation of thioredoxin antioxidative function in hyperglycemia. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Induction of Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "in Hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "Enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "Oxidative StressSince"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "contributes to the development of vascular complications"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   748   C0005847:vascular [Body Part, Organ, or Organ Component]
   748   C0009566:Complications [Pathologic Function]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1171258:complications [Pathologic Function]
   748   C1527148:Development [Functional Concept]
   748   C1558950:VASCULAR [Finding]
   748   C1801960:Vascular [Qualitative Concept]
   748   C1880177:Contribute [Activity]
   746   C1160250:blood vessel development [Organ or Tissue Function]
   714 E C2362589:Complication [Idea or Concept]

Phrase: "in diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the regulation of thioredoxin antioxidative function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "in hyperglycemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]
Processing 00000000.tx.67: Human aortic SMCs incubated with increasing concentrations of glucose showed a concentration-dependent reduction of thioredoxin activity (25 mM glucose: 55  19% versus base line, p < 0.01; 

Phrase: "Human aortic SMCs"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   897   C0427861:Human cells [Laboratory or Test Result]
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   804   C0003483:Aortic [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0086418:Human [Human]
   804   C0205357:Smooth [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   733 E C0442025:Muscular [Spatial Concept]

Phrase: "incubated with increasing concentrations of glucose"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   783   C0427743:concentrations glucose [Laboratory Procedure]
   783   C1287281:concentrations glucose [Laboratory or Test Result]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0086045:Concentrations [Mental Process]
   753   C0442808:Increasing [Functional Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a concentration-dependent reduction of thioredoxin activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C2267000:Reduction Activity [Molecular Function]
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(25 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ":"

Phrase: "55  19%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: "versus"

Phrase: "base line,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0168634:baseline [Biomedical or Dental Material]
  1000   C1442488:Baseline [Quantitative Concept]
   861   C0002055:base [Inorganic Chemical]
   861   C0178499:Base [Chemical Viewed Functionally]
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1880279:Base [Biomedical or Dental Material]
   789 E C0205112:Basal [Spatial Concept]
   777 E C0016617:Foundation [Organization]
   777 E C1626935:Bases [Quantitative Concept]

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.68: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.69: 1A). 

Phrase: "1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.70: Thioredoxin can be oxidized through interaction with hydrogen peroxide (11), which can be measured by the cell-permeable and redox-sensitive compound DCFDA (6). 

Phrase: "Thioredoxin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "can"

Phrase: "be"

Phrase: "oxidized through interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1704675:Interaction [Functional Concept]
   756   C0030011:oxidize [Molecular Function]

Phrase: "with hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "can"

Phrase: "be"

Phrase: "measured by the cell-permeable"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0007634:Cell [Cell]
   760   C0205326:Permeable [Functional Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "redox-sensitive compound DCFDA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0369114:Diacetate [Organic Chemical]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.71: Incubation of SMCs with glucose increased intracellular levels of ROS as assessed by DCFDA fluorescence in a concentration-dependent matter (10 mM glucose: +40.2  8.5%; 

Phrase: "Incubation of SMCs"

Phrase: "with glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "intracellular levels of ROS"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "as"

Phrase: "assessed by DCFDA fluorescence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C0369114:Diacetate [Organic Chemical]
   760   C1516048:Assessed [Activity]

Phrase: "in a concentration-dependent matter"

Phrase: "(10 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ":"

Phrase: "+40.2  8.5%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439509:/40 [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.72: p < 0.01 versus 5.6 mM glucose and 25 mM glucose: +76.3  2.7%; 

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "5.6 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "25 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ":"

Phrase: "+76.3  2.7%"

Phrase: ";"
Processing 00000000.tx.73: p < 0.001 versus 5.6 mM glucose). 

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "5.6 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.74: Glucose incubation did not change the expression of thioredoxin mRNA or protein levels (Fig. 1B). 

Phrase: "Glucose incubation"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "the expression of thioredoxin mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1515670:mRNA Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0428479:Protein level [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.75: However, incubation with glucose markedly induced expression of Txnip (18.6  6.4-fold versus base line; p < 0.05; Fig. 1B) both in cells stimulated with 25 mM glucose after being cultured for 48 h with 5.6 mM glucose (340  64%) and cells cultured in glucose-free medium (440  112% versus base line; p < 0.05). 

Phrase: "However,"

Phrase: "incubation with glucose markedly induced expression of Txnip"

Phrase: "(18.6  6.4-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: "versus"

Phrase: "base line"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0168634:baseline [Biomedical or Dental Material]
  1000   C1442488:Baseline [Quantitative Concept]
   861   C0002055:base [Inorganic Chemical]
   861   C0178499:Base [Chemical Viewed Functionally]
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1880279:Base [Biomedical or Dental Material]
   789 E C0205112:Basal [Spatial Concept]
   777 E C0016617:Foundation [Organization]
   777 E C1626935:Bases [Quantitative Concept]

Phrase: "; p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: "both in cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "stimulated with 25 mM glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "after"

Phrase: "being"

Phrase: "cultured for 48 h"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "with 5.6 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(340  64%"

Phrase: ")"

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "cultured in glucose-free medium"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   781   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0332296:free [Functional Concept]
   760   C0439536:Medium [Quantitative Concept]
   760   C1705217:Medium [Substance]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   760   C3244283:medium [Intellectual Product]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "(440  112%"

Phrase: "versus"

Phrase: "base line"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0168634:baseline [Biomedical or Dental Material]
  1000   C1442488:Baseline [Quantitative Concept]
   861   C0002055:base [Inorganic Chemical]
   861   C0178499:Base [Chemical Viewed Functionally]
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1880279:Base [Biomedical or Dental Material]
   789 E C0205112:Basal [Spatial Concept]
   777 E C0016617:Foundation [Organization]
   777 E C1626935:Bases [Quantitative Concept]

Phrase: "; p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.76: Co-incubation with insulin had no effect on the regulation of Txnip suggesting that glucose directly and independently regulates Txnip expression (Fig. 1C). 

Phrase: "Co-incubation with insulin"

Phrase: "had"

Phrase: "no effect on the regulation of Txnip"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1301751:No effect [Qualitative Concept]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that glucose directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "independently"

Phrase: "regulates"

Phrase: "Txnip expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1171362:protein expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.77: Co-immunoprecipitation studies showed that the hyperglycemia-induced increase in Txnip protein levels enhanced the thioredoxin/Txnip protein interaction (Fig. 1D). 

Phrase: "Co-immunoprecipitation studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C1449705:Co-Immunoprecipitation [Laboratory Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the hyperglycemia-induced increase in Txnip protein levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "the thioredoxin/Txnip protein interaction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   867   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   861   C0872079:Protein-Protein Interaction [Molecular Function]
           protein interaction
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1704675:Interaction [Functional Concept]

Phrase: "(Fig. 1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416886:1D [Gene or Genome]
   861   C1442449:1D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.78: The induction of Txnip by glucose was also found in several primary and non-primary cells such as neonatal rat cardiomyocytes (17.0  5.1-fold; p < 0.01), human endothelial cells (8.9  2.3-fold; p < 0.01), HeLa cells (4.71  2.6-fold; p < 0.05), SOL8 myoblasts (+24.0  13.0-fold; p < 0.001) and NIH 3T3 fibroblasts (+9.6  4.6-fold; p < 0.05; data not shown). 

Phrase: "The induction of Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "also"

Phrase: "found in several primary"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0150312:Found [Quantitative Concept]
   770   C0205225:Primary [Qualitative Concept]
   770   C0439631:Primary [Therapeutic or Preventive Procedure]
   737 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "non-primary cells such as neonatal rat cardiomyocytes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(17.0  5.1-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: "; p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "human endothelial cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0427861:Human cells [Laboratory or Test Result]
   901   C0225336:Endothelial Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0086418:Human [Human]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(8.9  2.3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: "; p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(4.71  2.6-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: "; p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "SOL8 myoblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596995:Myoblasts [Cell]

Phrase: "(+24.0  13.0-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: "; p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "NIH 3T3 fibroblasts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1257739:NIH/3T3 [Cell]
   827   C0016030:Fibroblasts [Cell]
   827   C0027468:NIH [Health Care Related Organization]

Phrase: "(+9.6  4.6-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: "; p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.79: Thus, glucose-mediated regulation of thioredoxin through Txnip appears to be a ubiquitous mechanism. 

Phrase: "Thus,"

Phrase: "glucose-mediated regulation of thioredoxin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "through Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a ubiquitous mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.80: View larger version (26K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.81: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.82: Hyperglycemia promotes the formation of ROS through induction of Txnip. 

Phrase: "Hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the formation of ROS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "through induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of Txnip."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.83: A, glucose incubation results in a concentration-dependent decrease of thioredoxin (Trx) activity in vascular smooth muscle cells compared with controls (5.6 mM). 

Phrase: "A,"

Phrase: "glucose incubation"

Phrase: "results in a concentration-dependent decrease of thioredoxin (Trx) activity"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   764   C1325405:thioredoxin activity [Molecular Function]
   742   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0086045:Concentration [Mental Process]
   742   C0205177:Activity [Functional Concept]
   742   C0392756:Decrease [Qualitative Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C0547047:Decrease [Quantitative Concept]
   742   C0851827:Dependent [Qualitative Concept]
   742   C1274040:Result [Functional Concept]
   742   C1446561:Concentration [Quantitative Concept]
   742   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C1546471:Result [Idea or Concept]
   742   C1561536:*Activity [Idea or Concept]
   742   C1701901:Dependent [Qualitative Concept]
   742   C2825142:Result [Finding]
   742   C3244310:dependent [Functional Concept]
   742   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "in vascular smooth muscle cells"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(5.6 mM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0442749:5 6 [Finding]

Phrase: ")."
Processing 00000000.tx.84: B, Txnip expression is regulated by glucose in a time-dependent manner without significant differences in Trx expression. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Txnip expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1171362:protein expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]

Phrase: "is"

Phrase: "regulated by glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "in a time-dependent manner"

Phrase: "without significant differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "in Trx expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.85: Txnip mRNA (top) increases as early as 1 h of incubation with glucose (25 mM). 

Phrase: "Txnip mRNA ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]

Phrase: "top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "increases as early"
Meta Candidates (Total=9; Excluded=7; Pruned=0; Remaining=2)
   790   C0442805:Increase [Functional Concept]
   790   C1279919:Early [Temporal Concept]
   734 E C1517378:Gain [Quantitative Concept]
   706 E C0205217:Increased [Quantitative Concept]
   706 E C0439661:Acquired [Temporal Concept]
   706 E C0442808:Increasing [Functional Concept]
   706 E C1301820:Obtain [Functional Concept]
   706 E C1706701:Acquire [Activity]
   706 E C3245488:acquired [Intellectual Product]

Phrase: "as 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of incubation"

Phrase: "with glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(25 mM"

Phrase: ")."
Processing 00000000.tx.86: Txnip protein levels (bottom) increase after 2 h of incubation with glucose. 

Phrase: "Txnip protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   836   C0428479:Protein level [Laboratory or Test Result]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]
   717   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "increase after 2 h of incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "with glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.87: C, the expression of Txnip mRNA is regulated by glucose independent from insulin (100 nM). 

Phrase: "C,"

Phrase: "the expression of Txnip mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1171362:expression protein [Genetic Function]
   774   C1515670:mRNA Expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "regulated by glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "independent from insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0085862:Independent [Idea or Concept]
   790   C1299583:Independent [Finding]

Phrase: "(100 nM)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.88: Induction of Txnip expression by hyperglycemia (25 mM glucose) is detectable after 4 h of stimulation in the absence and in the presence of insulin. 

Phrase: "Induction of Txnip expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "(25 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "is"

Phrase: "detectable after 4 h of stimulation"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "and in the presence of insulin."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1515981:And [Idea or Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.89: D, hyperglycemia enhances the interaction of Txnip with Trx. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the interaction of Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0872079:interaction protein [Molecular Function]
   753   C1704675:Interaction [Functional Concept]

Phrase: "with Trx."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.90: Cells were stimulated with glucose (25 mM) and total proteins extracted. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stimulated with glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "(25 mM)"

Phrase: "and"

Phrase: "total proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0555903:Total protein [Laboratory Procedure]
   966   C1261360:total protein [Laboratory or Test Result]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "extracted."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]
Processing 00000000.tx.91: Immunoprecipitation of Trx was performed using protein G-Sepharose beads coated with a monoclonal anti-Txnip antibody. 

Phrase: "Immunoprecipitation of Trx"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "protein G-Sepharose beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0991566:Beads [Biomedical or Dental Material]
   779 E C2346972:Bead [Spatial Concept]

Phrase: "coated with a monoclonal anti-Txnip antibody."
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   790   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   764   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   762   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0443737:Monoclonal protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0700271:monoclonal protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C1317659:Protein.monoclonal [Laboratory or Test Result]
   745   C1423498:coat-protein [Gene or Genome]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0746619:monoclonal [Finding]
   742   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C1522408:Coated [Qualitative Concept]
   742   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   708 E C0453946:Coat [Manufactured Object]
   708 E C2987482:Coat [Body Part, Organ, or Organ Component]
Processing 00000000.tx.92: Uncoated beads and beads coated with unspecific IgG served as controls. 

Phrase: "Uncoated beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0991566:Beads [Biomedical or Dental Material]
   827 E C2346972:Bead [Spatial Concept]

Phrase: "and"

Phrase: "beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "coated with unspecific IgG"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C1522408:Coated [Qualitative Concept]
   737 E C0453946:Coat [Manufactured Object]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "served as controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.93: Lanes 1 and 2 show levels of Trx in total cell lysates, lanes 3 and 4 show negative controls, and lanes 5 and 6 show immunoprecipitated Trx. 

Phrase: "Lanes 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "levels of Trx"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "in total cell lysates,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "lanes 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "4"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "negative controls,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C1639518:% negative control [Quantitative Concept]
   966   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "lanes 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "6"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "immunoprecipitated Trx."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.94: E, incubation with increasing concentrations of glucose induces levels of reactive oxygen species as detected by DCFDA fluorescence. 

Phrase: "E,"

Phrase: "incubation with increasing concentrations of glucose"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "levels of reactive oxygen species"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "as"

Phrase: "detected by DCFDA fluorescence."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C0369114:Diacetate [Organic Chemical]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.95: Adenoviral gene transfer of Txnip increases levels of reactive oxygen species in hyperglycemia; 

Phrase: "Adenoviral gene transfer of Txnip"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1517499:Gene Transfer [Molecular Biology Research Technique]
   774   C0751455:gene protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1336690:Thioredoxin Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]
   748   C0040671:Transfer [Mental Process]
   748   C1705822:Transfer [Activity]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "levels of reactive oxygen species"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.96: this was inhibited by overexpression of Trx. 

Phrase: "this"

Phrase: "was"

Phrase: "inhibited by overexpression of Trx."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0311403:Inhibited [Qualitative Concept]
   760   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1514559:Overexpression [Genetic Function]
   760   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.97: Cells were infected with adenoviral vectors for overexpression of Txnip, Trx, or GFP alone (controls). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "infected with adenoviral vectors"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   816   C1510800:Adenoviral Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0001483:Adenoviral [Virus]
   770   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0439663:Infected [Functional Concept]
   770   C0442335:Vectors [Spatial Concept]
   737 E C1705099:Vector [Idea or Concept]

Phrase: "for overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]

Phrase: "of Txnip,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Trx,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "or"

Phrase: "GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.98: After 48 h, cells were stimulated with glucose (10 and 25 mM). 

Phrase: "After 48 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stimulated with glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "(10"

Phrase: "and"

Phrase: "25 mM"

Phrase: ")."
Processing 00000000.tx.99: 45 min before the end of the experiments, 10 M DCFDA was added to the medium. 

Phrase: "45 min before the end of the experiments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0702093:/min [Temporal Concept]

Phrase: "10 M DCFDA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0369114:Diacetate [Organic Chemical]

Phrase: "was"

Phrase: "added to the medium."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1524062:Added [Functional Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.100: Cells were washed in Hank's balanced salt solution and fluorescence intensity measured on a fluorescence plate reader. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed in Hank's balanced salt solution"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   833   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]
   773   C0598357:balance salt [Organism Function]
   753   C0036140:Salt [Chemical Viewed Structurally]
   753   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0037633:Solution [Substance]
   753   C0205415:Balanced [Functional Concept]
   753   C0206136:Salt [Food,Inorganic Chemical]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C1423529:HANK [Gene or Genome]
   753   C1548982:Washed [Idea or Concept]
   719 E C0014653:Balance [Organism Function]
   719 E C0441648:Wash [Activity]
   719 E C0560184:Balance [Finding]

Phrase: "and"

Phrase: "fluorescence intensity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0522510:Intensity [Qualitative Concept]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "measured on a fluorescence plate reader."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0005971:Plate [Medical Device]
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0444706:Measured [Qualitative Concept]
   753   C1139930:plate [Medical Device]
   753   C1514743:Reader [Professional or Occupational Group]
   753   C1706461:Reader [Manufactured Object]
   753   C3537155:Plate [Manufactured Object]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.101: Fluorescence intensity was background-corrected and expressed as percent increase compared with non-stimulated cells of each group (n = 26 per data point). 

Phrase: "Fluorescence intensity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0522510:Intensity [Qualitative Concept]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "background-corrected"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205202:Corrected [Qualitative Concept]
   827 E C2349182:Correct [Qualitative Concept]

Phrase: "and"

Phrase: "expressed as percent increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439165:Percent [Quantitative Concept]
   770   C0442805:Increase [Functional Concept]

Phrase: "compared with non-stimulated cells of each group"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   744   C0007634:Cells [Cell]
   744   C0441833:Group [Idea or Concept]
   744   C0687744:group [Population Group]
   744   C1257890:Group [Population Group]
   744   C1518422:Non [Functional Concept]
   744   C1552516:Group [Health Care Related Organization]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]
   744   C1707455:Compared [Activity]
   744   C1948023:Stimulated [Natural Phenomenon or Process]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(n = 26 per data point"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1511726:Data Point [Idea or Concept]
           Data
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441922:N+ [Intellectual Product]
   760   C1552961:Point [Quantitative Concept]
   760   C1553036:[n] [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]
   760   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.102: F, gene silencing of Txnip reduces protein levels of Txnip. 

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "gene silencing of Txnip"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0598496:Gene Silencing [Genetic Function]
   783   C0751455:gene protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1336690:Thioredoxin Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   719   C0858952:silence [Mental or Behavioral Dysfunction]

Phrase: "reduces"

Phrase: "protein levels of Txnip."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   820   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   756   C0428479:Protein level [Laboratory or Test Result]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.103: G, gene silencing of Txnip prevents the glucose-induced reduction of Trx activity. 

Phrase: "G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "gene silencing of Txnip"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0598496:Gene Silencing [Genetic Function]
   783   C0751455:gene protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1336690:Thioredoxin Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   719   C0858952:silence [Mental or Behavioral Dysfunction]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the glucose-induced reduction of Trx activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C2267000:Reduction Activity [Molecular Function]
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.104: Cells were transfected with Txnip silencing or scrambled RNAi for 48 h before Trx activity was assessed (n = 12 per data point). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with Txnip silencing"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   719   C0858952:silence [Mental or Behavioral Dysfunction]

Phrase: "or"

Phrase: "scrambled RNAi for 48 h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1136031:RNAi [Genetic Function]

Phrase: "before Trx activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1325405:thioredoxin activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "(n = 12 per data point"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1511726:Data Point [Idea or Concept]
           Data
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441922:N+ [Intellectual Product]
   760   C1552961:Point [Quantitative Concept]
   760   C1553036:[n] [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]
   760   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.105: H, cellular levels of ROS in hyperglycemia were also reduced by gene silencing of Txnip as compared with scrambled RNAi (n = 25 per data point). 

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "cellular levels of ROS"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "were"

Phrase: "also"

Phrase: "reduced by gene silencing of Txnip"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   770   C0598496:Gene Silencing [Genetic Function]
   767   C0751455:gene protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1336690:Thioredoxin Gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0392756:Reduced [Qualitative Concept]
   744   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   711   C0858952:silence [Mental or Behavioral Dysfunction]

Phrase: "as"

Phrase: "compared with scrambled RNAi"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1136031:RNAi [Genetic Function]
   770   C1707455:Compared [Activity]

Phrase: "(n = 25 per data point"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1511726:Data Point [Idea or Concept]
           Data
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441922:N+ [Intellectual Product]
   760   C1552961:Point [Quantitative Concept]
   760   C1553036:[n] [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]
   760   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.106: *, p < 0.05 compared with non-stimulated cells. 

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with non-stimulated cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C1518422:Non [Functional Concept]
   760   C1707455:Compared [Activity]
   760   C1948023:Stimulated [Natural Phenomenon or Process]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.107: **, p < 0.01 compared with non-stimulated cells. 

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with non-stimulated cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C1518422:Non [Functional Concept]
   760   C1707455:Compared [Activity]
   760   C1948023:Stimulated [Natural Phenomenon or Process]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.108: ***, p < 0.001 compared with non-stimulated cells. 

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with non-stimulated cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C1518422:Non [Functional Concept]
   760   C1707455:Compared [Activity]
   760   C1948023:Stimulated [Natural Phenomenon or Process]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.109: , p < 0.05 versus scrambled RNAi.  

Phrase: ", p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "scrambled RNAi."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1136031:RNAi [Genetic Function]
Processing 00000000.tx.110: Overexpression of Txnip using adenoviral gene transfer resulted in increased cellular levels of ROS at 10 mM glucose (+68.8  32.9% versus AdGFP-infected cells; p < 0.01) and at 25 mM glucose (+95.8  15.1% versus AdGFP-infected cells; p < 0.001). 

Phrase: "Overexpression of Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "adenoviral gene transfer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1517499:Gene Transfer [Molecular Biology Research Technique]
   827   C0017337:Gene [Gene or Genome]
   827   C0040671:Transfer [Mental Process]
   827   C1705822:Transfer [Activity]

Phrase: "resulted in increased cellular levels of ROS"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   790   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   742   C0007634:Cellular [Cell]
   742   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0178539:Cellular [Functional Concept]
   742   C0205217:Increased [Quantitative Concept]
   742   C0205332:Reactive [Qualitative Concept]
   742   C0441889:Levels [Qualitative Concept]
   742   C0442805:Increased [Functional Concept]
   742   C1705920:Species [Conceptual Entity]
   708 E C0456079:Level [Classification]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708 E C1547707:Level [Geographic Area]
   708   C2825142:Result [Finding]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "at 10 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(+68.8  32.9%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450387:68 [Intellectual Product]

Phrase: "versus"

Phrase: "AdGFP-infected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "; p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and at 25 mM glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C1515981:And [Idea or Concept]

Phrase: "(+95.8  15.1%"

Phrase: "versus"

Phrase: "AdGFP-infected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "; p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.111: In contrast, overexpression of thioredoxin strongly inhibited the increase in ROS at both 10 and 25 mM glucose (Fig. 1E). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "overexpression of thioredoxin strongly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the increase in ROS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "at both 10"

Phrase: "and"

Phrase: "25 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(Fig. 1E"

Phrase: ")."
Processing 00000000.tx.112: These findings are consistent with previous reports showing the functional effects of adenoviral gene transfer of Txnip and thioredoxin (13, 14). 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "consistent with previous reports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the functional effects of adenoviral gene transfer of Txnip"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C1280500:effects [Qualitative Concept]
   704 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "thioredoxin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.113: Overexpression of Txnip results in increased protein levels of Txnip (>30-fold) and functional inhibition of thioredoxin activity by 61  23%. 

Phrase: "Overexpression of Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "results in increased protein levels of Txnip"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   784   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205217:Increased [Quantitative Concept]
   742   C0441889:Levels [Qualitative Concept]
   742   C0442805:Increased [Functional Concept]
   742   C1274040:Result [Functional Concept]
   742   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C1546471:Result [Idea or Concept]
   742   C2825142:Result [Finding]
   742   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   731   C0428479:Protein level [Laboratory or Test Result]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "("

Phrase: ">30-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "and"

Phrase: "functional inhibition of thioredoxin activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "by 61  23%."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.114: In turn, adenoviral gene transfer of thioredoxin increases thioredoxin protein levels (>20-fold) and thioredoxin activity by 270  40% (14). 

Phrase: "In turn,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "adenoviral gene transfer of thioredoxin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1517499:Gene Transfer [Molecular Biology Research Technique]
   797   C1336690:Thioredoxin Gene [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]
   760   C0040671:Transfer [Mental Process]
   760   C1705822:Transfer [Activity]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "thioredoxin protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C0428479:Protein level [Laboratory or Test Result]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "("

Phrase: ">20-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "and"

Phrase: "thioredoxin activity by 270  40%"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1325405:thioredoxin activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.115: Txnip gene knockdown induced through post-transcriptional interference of specifically designed Txnip RNAi (Fig. 1F) inhibited the hyperglycemia-induced reduction of thioredoxin activity (96.6  15.3% of base-line activity in cell transfected with Txnip RNAi versus 58.4  19.3% in cells transfected with scrambled RNAi under 25 mM glucose; p < 0.05; Fig. 1G). 

Phrase: "Txnip gene knockdown"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C2350567:Gene Knockdown [Molecular Biology Research Technique]
   717   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   708   C1336690:Thioredoxin Gene [Gene or Genome]

Phrase: "induced through post-transcriptional interference of specifically designed Txnip RNAi"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0040649:Transcriptional [Genetic Function]
   736   C0205263:Induced [Functional Concept]
   736   C0521102:Interference [Qualitative Concept]
   736   C0687676:Post [Temporal Concept]
   736   C1136031:RNAi [Genetic Function]
   736   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   736   C1704687:Post [Manufactured Object]
   736   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   703   C1707689:Design [Activity]
   703   C2983265:DESIGN [Intellectual Product]

Phrase: "(Fig. 1F"

Phrase: ")"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the hyperglycemia-induced reduction of thioredoxin activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C2267000:Reduction Activity [Molecular Function]
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(96.6  15.3% of base-line activity"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0168634:baseline [Biomedical or Dental Material]
   770   C1442488:Baseline [Quantitative Concept]
   744   C0002055:base [Inorganic Chemical]
   744   C0178499:Base [Chemical Viewed Functionally]
   744   C0205132:Line [Spatial Concept]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1550648:Line [Substance]
   744   C1552960:Line [Quantitative Concept]
   744   C1561536:*Activity [Idea or Concept]
   744   C1880279:Base [Biomedical or Dental Material]

Phrase: "in cell"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0007634:Cell [Cell]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "transfected with Txnip RNAi"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1136031:RNAi [Genetic Function]
   753   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "versus"

Phrase: "58.4  19.3% in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with scrambled RNAi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1136031:RNAi [Genetic Function]

Phrase: "under 25 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "; p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Fig. 1G"

Phrase: ")."
Processing 00000000.tx.116: Furthermore, gene knockdown of Txnip reduced the glucose-induced increase in oxidative stress by 27.4  1.1% under 10 mM glucose and by 35.8  9.8% under 25 mM glucose compared with controls (both p < 0.05 versus scrambled RNAi) without significant differences at base line (Fig. 1H). 

Phrase: "Furthermore,"

Phrase: "gene knockdown of Txnip"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2350567:Gene Knock-Down [Molecular Biology Research Technique]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the glucose-induced increase in oxidative stress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "by 27.4  1.1%"

Phrase: "under 10 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and by 35.8  9.8%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515981:And [Idea or Concept]

Phrase: "under 25 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "("

Phrase: "both p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "scrambled RNAi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1136031:RNAi [Genetic Function]

Phrase: ")"

Phrase: "without significant differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "at base line"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0168634:baseline [Biomedical or Dental Material]
  1000   C1442488:Baseline [Quantitative Concept]
   861   C0002055:base [Inorganic Chemical]
   861   C0178499:Base [Chemical Viewed Functionally]
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1880279:Base [Biomedical or Dental Material]
   789 E C0205112:Basal [Spatial Concept]
   777 E C0016617:Foundation [Organization]
   777 E C1626935:Bases [Quantitative Concept]

Phrase: "(Fig. 1H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442450:1H [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.117: These findings support the specific inhibition of the thioredoxin antioxidative system in hyperglycemia through induction of Txnip, the endogenous inhibitor of thioredoxin function. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the specific inhibition of the thioredoxin antioxidative system"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "in hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "through induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of Txnip,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the endogenous inhibitor of thioredoxin function."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205227:Endogenous [Functional Concept]
   753   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.118: Induction of Txnip in Hyperglycemia Is Mediated by p38 MAPKWe next analyzed the underlying cellular signaling mechanisms that regulate glucose-induced expression of Txnip. 

Phrase: "Induction of Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "in Hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "Is"

Phrase: "Mediated by p38 MAPKWe next"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0205117:next [Spatial Concept]
   760   C0332282:Next [Temporal Concept]
   760   C1883708:Next [Temporal Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the underlying cellular signaling mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0441712:Mechanisms [Functional Concept]
   779 E C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "regulate"

Phrase: "glucose-induced expression of Txnip."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.119: Incubation of aortic SMCs with hyperglycemic concentrations of glucose (25 mM) resulted in a phosphorylation of p38 MAPK after 30 min that was prevented by preincubation with the p38 MAPK inhibitor PD169316 (Fig. 2A). 

Phrase: "Incubation of aortic SMCs"

Phrase: "with hyperglycemic concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(25 mM)"

Phrase: "resulted in a phosphorylation of p38 MAPK"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1120843:MAPK, p38 [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "after 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "that"

Phrase: "was"

Phrase: "prevented by preincubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "with the p38 MAPK inhibitor PD169316"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0914485:PD169316 [Organic Chemical]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.120: In addition, inhibition of p38 MAPK abolished the glucose-induced expression of Txnip mRNA (Fig. 2B) and protein (Fig. 2C). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "inhibition of p38 MAPK"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "abolished"

Phrase: "the glucose-induced expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of Txnip mRNA (Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0450354:2b [Intellectual Product]
   799   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: "and"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.121: Therefore, glucose-induced activation of p38 MAPK is required for the induction of Txnip expression. 

Phrase: "Therefore,"

Phrase: "glucose-induced activation of p38 MAPK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1155551:MAPK activation [Molecular Function]
   753   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "required for the induction of Txnip expression."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   764   C1171362:protein expression [Genetic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0205263:Induction [Functional Concept]
   742   C0857127:induction [Therapeutic or Preventive Procedure]
   742   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C1514873:Required [Functional Concept]
   742   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.122: View larger version (30K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.123: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.124: Transcriptional Regulation of Txnip. 

Phrase: "Transcriptional Regulation of Txnip."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1158770:Transcriptional Regulation [Genetic Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.125: A, incubation with D(+)-glucose (25 mM) induces activation of p38 MAPK. 

Phrase: "A,"

Phrase: "incubation with"

Phrase: "D(+)-"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(25 mM)"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "activation of p38 MAPK."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1155551:MAPK activation [Molecular Function]
   770   C1879547:Activation [Activity]
Processing 00000000.tx.126: Inhibition of p38 MAPK blocks the glucose-induced expression of Txnip mRNA and protein. 

Phrase: "Inhibition of p38 MAPK"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the glucose-induced expression of Txnip mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1171362:expression protein [Genetic Function]
   762   C1515670:mRNA Expression [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.127: Incubation with L(+)-glucose (25 mM) has no effects on the expression of Txnip (B and C). 

Phrase: "Incubation with L(+)-glucose"

Phrase: "(25 mM)"

Phrase: "has"

Phrase: "no effects on the expression of Txnip"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C1301751:No effect [Qualitative Concept]
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.128: D, PDGF-BB (4 ng/ml) induces phosphorylation of Akt that is inhibited in hyperglycemia (25 mM). 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "PDGF-BB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0246681:PDGF-BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0004739:BB [Geographic Area]
   861   C0032200:PDGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332297:BB [Spatial Concept]

Phrase: "(4 ng/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439275:ng/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "phosphorylation of Akt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "that"

Phrase: "is"

Phrase: "inhibited in hyperglycemia"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0020456:Hyperglycaemia [Disease or Syndrome]
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "(25 mM"

Phrase: ")."
Processing 00000000.tx.129: E, activation of PI 3-kinase by PDGF-BB negatively regulates Txnip mRNA expression whereas the PI 3-kinase inhibitor wortmannin increases expression of Txnip. 

Phrase: "E,"

Phrase: "activation of PI 3-kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "by PDGF-BB negatively"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0246681:PDGF-BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0004739:BB [Geographic Area]
   827   C0032200:PDGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332297:BB [Spatial Concept]

Phrase: "regulates"

Phrase: "Txnip mRNA expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C1171362:protein expression [Genetic Function]
   840   C1515670:mRNA Expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   717   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]

Phrase: "whereas"

Phrase: "the PI 3-kinase inhibitor wortmannin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]
   717   C0044602:PI 3 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0919338:PI-3 kinase [Gene or Genome]
   717   C2936824:PI-3 Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "expression of Txnip."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.130: *, p < 0.01 compared with controls. 

Phrase: "*,"

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.131: **, p < 0.05 compared with glucose-stimulated cells.  

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with glucose-stimulated cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C1707455:Compared [Activity]
   760   C1948023:Stimulated [Natural Phenomenon or Process]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.132: Activation of PI 3-Kinase Suppresses TxnipFurther experiments revealed enhanced glucose-induced expression of Txnip in the presence of the PI 3-kinase inhibitor wortmannin (31.4  19.9-fold versus 14.6  5.6-fold in glucose-stimulated cells; p < 0.05). 

Phrase: "Activation of PI 3-Kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "Suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "TxnipFurther experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "enhanced glucose-induced expression of Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of the PI 3-kinase inhibitor wortmannin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0078517:wortmannin [Biologically Active Substance,Pharmacologic Substance,Steroid]
   717   C0044602:PI 3 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0919338:PI-3 kinase [Gene or Genome]
   717   C2936824:PI-3 Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(31.4  19.9-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: "versus"

Phrase: "14.6  5.6-fold in glucose-stimulated cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332462:Fold [Spatial Concept]
   742   C1880834:FOLD [Phenomenon or Process]

Phrase: "; p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.133: No effects were detectable after incubation with the ERK inhibitor U0126, Gi inhibition by pertussis toxin, or protein kinase C (PKC) inhibition by GF109203X (data not shown). 

Phrase: "No effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "detectable after incubation"

Phrase: "with the ERK inhibitor U0126,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: "Gi inhibition by pertussis toxin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "or"

Phrase: "protein kinase C (PKC) inhibition by GF109203X"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.134: PKC activation (phorbol myristate acetate, 100 nM), a central mediator of glucose-induced cellular signaling mechanisms (17), did not affect the expression of Txnip. 

Phrase: "PKC activation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C3546691:protein kinase C activation [Molecular Function]
   923   C1819041:protein kinase activation [Cell Function]
   902   C0599177:protein activation [Genetic Function]
   812   C1879547:Activation [Activity]
   756   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   708   C1168438:Protein C [Laboratory Procedure]
   708   C1418943:PROTEIN C [Gene or Genome]
   708   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(phorbol myristate acetate,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039654:Phorbol Myristate Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   827   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   827   C0031588:phorbol [Organic Chemical]
   827   C0070750:Phorbol [Organic Chemical]
   827   C0129533:Myristate [Biologically Active Substance,Lipid,Pharmacologic Substance]

Phrase: "100 nM),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "a central mediator of glucose-induced cellular signaling mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the expression of Txnip."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.135: As shown previously (18), incubation of SMCs with hyperglycemic levels of glucose reduced the PI 3-kinase-dependent phosphorylation status of Akt in response to stimulation with PDGF-BB (4 ng/ml) (Fig. 2D). 

Phrase: "As"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously"

Phrase: "(18"

Phrase: ")"

Phrase: ","

Phrase: "incubation of SMCs"

Phrase: "with hyperglycemic levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the PI 3-kinase-dependent phosphorylation status of Akt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449438:Status [Qualitative Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with PDGF-BB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0246681:PDGF-BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0004739:BB [Geographic Area]
   861   C0032200:PDGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332297:BB [Spatial Concept]

Phrase: "(4 ng/ml) (Fig. 2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1705052:2D [Spatial Concept]
   804   C2986796:2D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.136: Activation of PI 3-kinase through stimulation with PDGF-BB reduced glucose-induced expression of Txnip mRNA by 45.4  16.4% (p < 0.01 versus non-stimulated cells) (Fig. 2E). 

Phrase: "Activation of PI 3-kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "through stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with PDGF-BB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0246681:PDGF-BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0004739:BB [Geographic Area]
   861   C0032200:PDGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332297:BB [Spatial Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "glucose-induced expression of Txnip mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1171362:expression protein [Genetic Function]
   767   C1515670:mRNA Expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by 45.4  16.4%"

Phrase: "(p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "non-stimulated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "(Fig. 2E"

Phrase: ")."
Processing 00000000.tx.137: Taken together, these findings indicate that the PI 3-kinase pathway inhibits Txnip expression, and its inhibition in hyperglycemia promotes the expression of Txnip. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the PI 3-kinase pathway"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]
   756   C0044602:PI 3 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0919338:PI-3 kinase [Gene or Genome]
   756   C2936824:PI-3 Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Txnip expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1171362:protein expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]

Phrase: "and"

Phrase: "its inhibition in hyperglycemia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the expression of Txnip."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.138: Vascular Regulation of Txnip in Diabetes Mellitus in VivoWe next investigated the functional regulation of the thioredoxin system in an animal model of diabetes mellitus in vivo. 

Phrase: "Vascular Regulation of Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "in Diabetes Mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: "in VivoWe next"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the functional regulation of the thioredoxin system"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "in an animal model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599779:Animal Model [Animal]
   861   C0003062:Animal [Animal]
   861   C3161035:Model [Intellectual Product]

Phrase: "of diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.139: The diabetic state was induced in adult rats through intraperitoneal injection of STZ. 

Phrase: "The diabetic state"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0241863:DIABETIC [Finding]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "was"

Phrase: "induced in adult rats"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0001675:Adult [Age Group]
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0205263:Induced [Functional Concept]
   770   C1706450:Adult [Human]

Phrase: "through intraperitoneal injection"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0021493:Intraperitoneal injection [Therapeutic or Preventive Procedure]
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C0442120:Intraperitoneal [Spatial Concept]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "of STZ."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038432:STZ [Antibiotic,Carbohydrate]
  1000   C1539862:STZ [Gene or Genome]
Processing 00000000.tx.140: First, we assessed increased formation of superoxide anion in vascular samples of animals with diabetes mellitus. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "we"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "increased formation of superoxide anion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "in vascular samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   950   C0178913:blood samples [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "of animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "with diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]
Processing 00000000.tx.141: Superoxide anion, an intermediate product of cellular redox scavenging pathways, can be detected on frozen tissue sections by the redox-sensitive compound DHE that is oxidized to a characteristic fluorescing and DNA-interacting product (1921). 

Phrase: "Superoxide anion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038836:Superoxide Anion [Element, Ion, or Isotope]
           Superoxide
   861   C0003075:Anion [Element, Ion, or Isotope]

Phrase: "an intermediate product of cellular redox scavenging pathways,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1514468:product [Entity]
   744   C1704444:Product [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "detected on frozen tissue sections"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   797   C0016741:Frozen Sections [Tissue]
   790   C2316368:Tissue section [Tissue]
   781 E C0085188:Frozen Section [Laboratory Procedure]
   760   C0016701:Frozen [Natural Phenomenon or Process]
   760   C0040300:Tissue [Tissue]
   760   C0442726:Detected [Finding]
   760   C0677542:Frozen [Functional Concept]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1547928:Tissue [Intellectual Product]
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]

Phrase: "by the redox-sensitive compound DHE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0006222:Bromide [Inorganic Chemical]

Phrase: "that"

Phrase: "is"

Phrase: "oxidized to a characteristic fluorescing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1521970:Characteristic [Qualitative Concept]
   726   C0030011:oxidize [Molecular Function]

Phrase: "and"

Phrase: "DNA-interacting product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "(1921"

Phrase: ")."
Processing 00000000.tx.142: Although superoxide is not directly scavenged by thioredoxin, which can efficiently scavenge hydrogen peroxide, increased vascular oxidative stress has been previously documented in diabetic animals with this method (21). 

Phrase: "Although"

Phrase: "superoxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038836:Superoxide [Element, Ion, or Isotope]

Phrase: "is"

Phrase: "not directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "scavenged by thioredoxin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "which"

Phrase: "can"

Phrase: "efficiently"

Phrase: "scavenge"

Phrase: "hydrogen peroxide,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "vascular oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "documented in diabetic animals"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0003062:Animals [Animal]
   770   C0241863:DIABETIC [Finding]
   770   C1301725:Documented [Health Care Activity]
   770   C1609436:documented [Idea or Concept]
   737 E C1301746:document [Intellectual Product]
   737 E C1547673:Document [Intellectual Product]

Phrase: "with this method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.143: DHE staining revealed increased levels of superoxide in vessels from diabetic animals compared with controls (Fig. 3A). 

Phrase: "DHE staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "increased levels of superoxide"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005847:Vessels [Body Part, Organ, or Organ Component]
   966 E C1511228:Vessel [Tissue]
   928 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "from diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.144: View larger version (34K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.145: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.146: Regulation of Trx function through Txnip in vivo. 

Phrase: "Regulation of Trx function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "through Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.147: A, animals with STZ-induced diabetes mellitus exhibit increased vascular levels of superoxide anion as detected by nuclear DHE staining as compared with non-diabetic controls. 

Phrase: "A,"

Phrase: "animals with STZ-induced diabetes mellitus exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0003062:Animals [Animal]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "vascular levels of superoxide anion"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "as"

Phrase: "detected by nuclear DHE staining"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0006222:Bromide [Inorganic Chemical]
   753   C0442726:Detected [Finding]
   753   C0487602:Staining [Laboratory Procedure]
   753   C0521447:Nuclear [Spatial Concept]
   753   C0644810:dihydroethidium [Organic Chemical,Pharmacologic Substance]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1704680:Staining [Finding]

Phrase: "as"

Phrase: "compared with non-diabetic controls."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0241863:DIABETIC [Finding]
   760   C1518422:Non [Functional Concept]
   760   C1707455:Compared [Activity]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.148: B, reduced vascular thioredoxin activity in diabetic animals compared with controls normalizes under insulin treatment (n = 6 per group). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "vascular thioredoxin activity in diabetic animals"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1325405:thioredoxin activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "normalizes under insulin treatment"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1705169:Treatment [Conceptual Entity]
   770   C1882115:Normalize [Research Activity]
   770   C3538994:TREATMENT [Research Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(n = 6 per group"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   819   C0441848:Group N [Intellectual Product]
   770   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441833:Group [Idea or Concept]
   770   C0441922:N+ [Intellectual Product]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1553036:[n] [Quantitative Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: ")."
Processing 00000000.tx.149: Increased vascular expression of Txnip is detectable in diabetes mellitus that normalizes under insulin treatment. 

Phrase: "Increased vascular expression of Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "detectable in diabetes mellitus"

Phrase: "that"

Phrase: "normalizes under insulin treatment."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1705169:Treatment [Conceptual Entity]
   770   C1882115:Normalize [Research Activity]
   770   C3538994:TREATMENT [Research Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.150: In contrast, no significant changes in Trx expression or protein levels were detectable (n = 9 per group). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "no significant changes in Trx expression"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   767   C0442739:No change [Finding]
   767   C1548568:No change [Intellectual Product]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "or"

Phrase: "protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0428479:Protein level [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "detectable"

Phrase: "(n = 9 per group"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0441848:Group N [Intellectual Product]
   770   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441922:N+ [Intellectual Product]
   770   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.151: *, p < 0.05 compared with controls (C and D). 

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.152: E, immunostaining reveals increased immunoreactivity of Txnip in the vascular media of vessels of diabetic animals without differences in Trx immunoreactivity. 

Phrase: "E,"

Phrase: "immunostaining"

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "increased immunoreactivity of Txnip"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597879:immunoreactivity [Molecular Function]

Phrase: "in the vascular media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0162867:Vascular Media [Tissue]
           Media
   861   C0009458:Media [Intellectual Product]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "of vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005847:Vessels [Body Part, Organ, or Organ Component]
   966 E C1511228:Vessel [Tissue]
   928 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "of diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "without differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "in Trx immunoreactivity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]
Processing 00000000.tx.153: Vascular tissues were isolated from the aorta of the animals.  

Phrase: "Vascular tissues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   955   C1511228:Blood Vessel Tissue [Tissue]
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "isolated from the aorta of the animals."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0003062:Animals [Animal]
   748   C0003483:Aorta [Body Part, Organ, or Organ Component]
   748   C0205409:Isolated [Functional Concept]
   748   C1278934:Aorta [Body Part, Organ, or Organ Component]
   748   C1548221:Isolated [Idea or Concept]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.154: Vascular thioredoxin activity was reduced in animals with diabetes mellitus compared with controls (26.7  22.6 versus 79.0  44.6 ng of thioredoxin per g of total protein; p < 0.01 versus base line) but normalized under insulin treatment (59.3  1.3 ng of thioredoxin per g of total protein; p = 0.78 versus base line; Fig. 3B). 

Phrase: "Vascular thioredoxin activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1325405:thioredoxin activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "reduced in animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003062:Animals [Animal]
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "with diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(26.7  22.6"

Phrase: "versus"

Phrase: "79.0  44.6 ng of thioredoxin"

Phrase: "per g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "of total protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0555903:Total protein [Laboratory Procedure]
  1000   C1261360:total protein [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "; p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "base line"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0168634:baseline [Biomedical or Dental Material]
  1000   C1442488:Baseline [Quantitative Concept]
   861   C0002055:base [Inorganic Chemical]
   861   C0178499:Base [Chemical Viewed Functionally]
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1880279:Base [Biomedical or Dental Material]
   789 E C0205112:Basal [Spatial Concept]
   777 E C0016617:Foundation [Organization]
   777 E C1626935:Bases [Quantitative Concept]

Phrase: ")"

Phrase: "but"

Phrase: "normalized under insulin treatment"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1705169:Treatment [Conceptual Entity]
   770   C1882115:Normalized [Research Activity]
   770   C3538994:TREATMENT [Research Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(59.3  1.3 ng of thioredoxin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0964553:NG.1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C1334110:NG.1 [Gene or Genome]

Phrase: "per g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "of total protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0555903:Total protein [Laboratory Procedure]
  1000   C1261360:total protein [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "; p = 0.78"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "base line"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0168634:baseline [Biomedical or Dental Material]
  1000   C1442488:Baseline [Quantitative Concept]
   861   C0002055:base [Inorganic Chemical]
   861   C0178499:Base [Chemical Viewed Functionally]
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1880279:Base [Biomedical or Dental Material]
   789 E C0205112:Basal [Spatial Concept]
   777 E C0016617:Foundation [Organization]
   777 E C1626935:Bases [Quantitative Concept]

Phrase: "; Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.155: Vascular expression of Txnip increased dramatically in diabetic animals (379.7  123.5% of base-line expression; p < 0.001) without changes in the expression of thioredoxin (83.8  41.9% of base-line expression; p = 0.83; Fig. 3C). 

Phrase: "Vascular expression of Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "dramatically in diabetic animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003062:Animals [Animal]
   770   C0241863:DIABETIC [Finding]

Phrase: "(379.7  123.5% of base-line expression"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0168634:baseline [Biomedical or Dental Material]
   770   C1442488:Baseline [Quantitative Concept]
   744   C0002055:base [Inorganic Chemical]
   744   C0178499:Base [Chemical Viewed Functionally]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205132:Line [Spatial Concept]
   744   C1550648:Line [Substance]
   744   C1552960:Line [Quantitative Concept]
   744   C1880279:Base [Biomedical or Dental Material]

Phrase: "; p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "without changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "in the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of thioredoxin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(83.8  41.9% of base-line expression"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0168634:baseline [Biomedical or Dental Material]
   770   C1442488:Baseline [Quantitative Concept]
   744   C0002055:base [Inorganic Chemical]
   744   C0178499:Base [Chemical Viewed Functionally]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205132:Line [Spatial Concept]
   744   C1550648:Line [Substance]
   744   C1552960:Line [Quantitative Concept]
   744   C1880279:Base [Biomedical or Dental Material]

Phrase: "; p = 0.83"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.156: Normalization of serum glucose by insulin treatment reduced Txnip expression to base-line levels (81.3  13.9% of base line; p = 0.79). 

Phrase: "Normalization of serum glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882115:Normalization [Research Activity]

Phrase: "by insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "Txnip expression to base-line levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1171362:protein expression [Genetic Function]
   750   C3244092:expression level [Idea or Concept]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(81.3  13.9% of base line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0168634:baseline [Biomedical or Dental Material]
   778   C1442488:Baseline [Quantitative Concept]
   748   C0002055:base [Inorganic Chemical]
   748   C0178499:Base [Chemical Viewed Functionally]
   748   C0205132:Line [Spatial Concept]
   748   C1550648:Line [Substance]
   748   C1552960:Line [Quantitative Concept]
   748   C1880279:Base [Biomedical or Dental Material]

Phrase: "; p = 0.79"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.157: In addition, vascular Txnip protein levels increased in diabetes mellitus and normalized with insulin treatment (Fig. 3D). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "vascular Txnip protein levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   822   C0428479:Protein level [Laboratory or Test Result]
   799   C0441889:Levels [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]

Phrase: "increased in diabetes mellitus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]

Phrase: "and"

Phrase: "normalized with insulin treatment"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1705169:Treatment [Conceptual Entity]
   770   C1882115:Normalized [Research Activity]
   770   C3538994:TREATMENT [Research Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(Fig. 3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.158: Immunohistochemical analysis of vascular sections showed strong immunoreactivity for Txnip in the media of aortas from diabetic animals with no changes in thioredoxin levels (Fig. 3E).  

Phrase: "Immunohistochemical analysis of vascular sections"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1441616:Immunohistochemical [Laboratory Procedure]
   760   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "strong immunoreactivity for Txnip"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597879:immunoreactivity [Molecular Function]

Phrase: "in the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "of aortas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003483:Aortas [Body Part, Organ, or Organ Component]
   966 E C1278934:Aorta [Body Part, Organ, or Organ Component]

Phrase: "from diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "with no changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "in thioredoxin levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 3E"

Phrase: ")."
Processing 00000000.tx.159: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  The thioredoxin system regulates cellular redox balance through the reversible oxidization of its redox-active cysteine residues (-Cys-Gly-Pro-Cys-) to form a disulfide bond that in turn is reduced by thioredoxin reductase and NADPH (11). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The thioredoxin system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "regulates"

Phrase: "cellular redox balance through the reversible oxidization of its redox-active cysteine residues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   735   C0014653:Balance [Organism Function]
   735   C0205415:Balance [Functional Concept]
   735   C0560184:Balance [Finding]

Phrase: "(-Cys-Gly-Pro-Cys-) to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   875   C0625284:Cys-Cys [Amino Acid, Peptide, or Protein]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a disulfide bond"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511997:Disulfide Bond [Amino Acid Sequence]
   861   C0012771:disulfide [Chemical Viewed Structurally]

Phrase: "that in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "is"

Phrase: "reduced by thioredoxin reductase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0039941:Thioredoxin Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0392756:Reduced [Qualitative Concept]
   770   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "NADPH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027303:NADPH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.160: Targeted deletion of thioredoxin causes early embryonic lethality (22). 

Phrase: "Targeted deletion of thioredoxin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "early embryonic lethality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1836107:Early lethality [Finding]
   755   C3151529:Lethal [Finding]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.161: The thioredoxin system compensates for a lack of glutathione reductase in Drosophila melanogaster, emphasizing the role of this system as a central and highly conserved antioxidative cellular defense mechanism (23). 

Phrase: "The thioredoxin system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "compensates for a lack of glutathione reductase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0017824:Glutathione Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1415326:GLUTATHIONE REDUCTASE [Gene or Genome]
   748   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205432:compensate [Qualitative Concept]
   748   C0332268:lack [Qualitative Concept]

Phrase: "in Drosophila melanogaster,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013139:Drosophila melanogaster [Eukaryote]
   861   C0013138:Drosophila [Eukaryote]
   861   C1028876:Drosophila [Fungus]
   861   C1034337:Melanogaster [Fungus]
   861   C1504613:Drosophila [Eukaryote]

Phrase: "emphasizing"

Phrase: "the role of this system"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "as a central"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205099:Central [Spatial Concept]
  1000   C1879652:Central - [Laboratory Procedure]

Phrase: "and"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "conserved"

Phrase: "antioxidative cellular defense mechanism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0011142:defense mechanism [Mental Process]
   812   C0441712:Mechanism [Functional Concept]
   812   C1706376:Mechanism [Manufactured Object]
   812   C1880266:Defense [Conceptual Entity]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.162: In endothelial cells, S-nitrosylation at Cys-69 is required for the anti-apoptotic and redox regulatory function of thioredoxin (24). 

Phrase: "In endothelial cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "S-"

Phrase: "nitrosylation at Cys-69"

Phrase: "is"

Phrase: "required for the anti-apoptotic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1512772:anti-apoptosis [Cell Function]
   760   C1514873:Required [Functional Concept]
   760   C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "redox regulatory function of thioredoxin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.163: In addition, thioredoxin functions as a crucial mediator of redox-mediated transcriptional activation (25, 26). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "thioredoxin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "functions as a crucial mediator of redox-mediated transcriptional activation"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   777   C1363844:Mediator of Activation [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Mediator
   760   C0162493:Transcriptional Activation [Genetic Function]
   757   C1321099:Activation function [Physiologic Function]
   739   C0030012:Redox [Molecular Function]
   739   C0031843:function [Physiologic Function]
   739   C0040649:Transcriptional [Genetic Function]
   739   C0086597:mediated [Social Behavior]
   739   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   739   C0542341:Function [Functional Concept]
   739   C0700205:FUNCTION [Classification]
   739   C1705273:Function [Intellectual Product]
   739   C1879547:Activation [Activity]

Phrase: "(25,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.164: After nuclear translocation, thioredoxin can bind by reduction of its redox-active cysteine residues to the transcriptional activator Ref-1, which in turn increases the DNA binding activity of AP-1 and also activates ribonucleotide reductase, a key enzyme in DNA synthesis (25). 

Phrase: "After nuclear translocation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1518440:Nuclear Translocation [Molecular Function]
   861   C0040715:Translocation [Cell or Molecular Dysfunction]
   861   C2987521:Translocation [Activity]

Phrase: "thioredoxin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "can"

Phrase: "bind by reduction of its redox-active cysteine residues"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   742   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0030012:Redox [Molecular Function]
   742   C0205177:Active [Functional Concept]
   742   C0301630:Reduction [Natural Phenomenon or Process]
   742   C0392756:Reduction [Qualitative Concept]
   742   C0441610:Reduction [Therapeutic or Preventive Procedure]
   742   C1145667:Bind [Activity]
   742   C1167622:bind [Molecular Function]
   708   C1709915:Residue [Conceptual Entity]
   708   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "to the transcriptional activator Ref-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1419349:activator 1 [Gene or Genome]
   861   C0140145:REF-1 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1332102:REF-1 [Gene or Genome]
   812   C1425988:REF [Gene or Genome]

Phrase: "which in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the DNA binding activity of AP-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C2266866:Binding Activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "also"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "ribonucleotide reductase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035547:Ribonucleotide Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0035548:Ribonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "a key enzyme in DNA synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0597548:synthetic enzyme [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.165: As part of the cellular stress response, cells express and release a truncated thioredoxin isoform (10 kDa) through a non-typical secretion pathway (27). 

Phrase: "As part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "of the cellular stress response,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1425942:CELLULAR STRESS RESPONSE [Gene or Genome]
  1000   C1516374:Cellular Stress Response [Cell Function]
   901   C0149784:stress response [Physiologic Function]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
   734   C1516373:Cellular Stress [Cell or Molecular Dysfunction]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "and"

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "a truncated thioredoxin isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "(10 kDa) through a non-typical secretion pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1532717:kDa [Quantitative Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.166: The truncated isoform has growth-inducing abilities and can act as a chemokine (27). 

Phrase: "The truncated isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "has"

Phrase: "growth-inducing abilities"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Abilities [Organism Attribute]
   743 E C1299581:Able [Finding]

Phrase: "and"

Phrase: "can"

Phrase: "act as a chemokine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079613:ACT [Therapeutic or Preventive Procedure]
   770   C0282554:chemokine [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.167: However, it lacks the reducing capacity of full-length thioredoxin and does not participate in the regulation of ROS (28). 

Phrase: "However,"

Phrase: "it"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the reducing capacity of full-length thioredoxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1516240:Capacity [Quantitative Concept]

Phrase: "and"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "participate in the regulation of ROS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   744   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0205332:Reactive [Qualitative Concept]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]
   744   C1705920:Species [Conceptual Entity]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.168: The endogenous thioredoxin inhibitor Txnip binds to the active site of thioredoxin and inhibits thioredoxin activity (15). 

Phrase: "The endogenous thioredoxin inhibitor Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   885   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds to the active site of thioredoxin"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0205681:Active Site [Functional Concept]
   778   C2945843:Site of [Qualitative Concept]
   748   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205145:Site [Spatial Concept]
   748   C0205177:Active [Functional Concept]
   748   C1145667:Bind [Activity]
   748   C1167622:bind [Molecular Function]
   748   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]
   748   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "thioredoxin activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1325405:thioredoxin activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.169: Txnip competes with other thioredoxin-binding proteins such as apoptosis-signaling kinase-1 (ASK1) (16) and inhibits the thioredoxin-mediated degradation of ASK1 through ubiquitination (29), thereby sensitizing cells to apoptotic stimuli (13). 

Phrase: "Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "competes with other thioredoxin-binding proteins"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767 E C0033618:Protein Binding [Molecular Function]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "such as apoptosis-signaling kinase-1 (ASK1)"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C1622858:apoptosis signaling [Cell Function]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0037083:Signaling [Cell Function]
   812   C0162638:Apoptosis [Cell Function]
   812   C3537152:signaling [Biologic Function]
   779 E C1710082:Signal [Phenomenon or Process]
   741 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(16"

Phrase: ")"

Phrase: "and"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the thioredoxin-mediated degradation of ASK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0243125:degradation [Functional Concept]
   742   C0699900:Degradation [Organism Function]

Phrase: "through ubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519751:Ubiquitination [Molecular Function]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "thereby sensitizing cells to apoptotic stimuli"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.170: In addition, Txnip prevents the nuclear translocation of thioredoxin (14) and regulates thioredoxin-dependent transcriptional mechanisms. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the nuclear translocation of thioredoxin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1518440:Nuclear Translocation [Molecular Function]
   760   C0040715:Translocation [Cell or Molecular Dysfunction]
   760   C2987521:Translocation [Activity]

Phrase: "(14"

Phrase: ")"

Phrase: "and"

Phrase: "regulates"

Phrase: "thioredoxin-dependent transcriptional mechanisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0441712:Mechanisms [Functional Concept]
   779 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.171: Txnip has been described as an intracellular protein that interacts with thioredoxin at its redox-active cysteine residues (15). 

Phrase: "Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "described as an intracellular protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C1552738:described [Idea or Concept]

Phrase: "that"

Phrase: "interacts with thioredoxin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "at its redox-active cysteine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.172: Since the thioredoxin/Txnip interaction occurs in the cytoplasm, we assume that it interacts only with thioredoxin-1. 

Phrase: "Since"

Phrase: "the thioredoxin/Txnip interaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0872079:protein interaction [Molecular Function]
   804   C1704675:Interaction [Functional Concept]
   722   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]

Phrase: "occurs in the cytoplasm,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010834:Cytoplasm [Cell Component]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "we"

Phrase: "assume"

Phrase: "that"

Phrase: "it"

Phrase: "interacts"

Phrase: "only with thioredoxin-1."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1956394:Thioredoxin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205171:Only [Quantitative Concept]
   770   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C1720467:Only [Intellectual Product]
   770   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.173: However, thioredoxin-2, the mitochondrial isoform of thioredoxin, also has the typical cysteine-containing motif, which potentially would allow the interaction with Txnip (30). 

Phrase: "However,"

Phrase: "thioredoxin-2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1425073:Thioredoxin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1456398:THIOREDOXIN 2 [Gene or Genome]
   861   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "the mitochondrial isoform of thioredoxin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "also"

Phrase: "has"

Phrase: "the typical cysteine-containing motif,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1514562:Motif [Amino Acid Sequence]

Phrase: "which potentially"

Phrase: "would"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "the interaction with Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0872079:interaction protein [Molecular Function]
   753   C1704675:Interaction [Functional Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.174: Since no data are known regarding mitochondrial localization of Txnip, we can only speculate whether this interaction can occur in living cells. 

Phrase: "Since"

Phrase: "no data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "regarding"

Phrase: "mitochondrial localization of Txnip,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1657244:mitochondrial localization [Biologic Function]
   783   C0597704:protein localisation [Cell Function]
   783   C1159772:Protein Localization [Cell Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "we"

Phrase: "can"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "speculate"

Phrase: "whether"

Phrase: "this interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "can"

Phrase: "occur in living cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0376558:Living [Idea or Concept]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.175: Our results demonstrate the inhibition of thioredoxin activity in hyperglycemia, which can be explained by the specific induction of Txnip, the endogenous inhibitor of thioredoxin. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "the inhibition of thioredoxin activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "in hyperglycemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "which"

Phrase: "can"

Phrase: "be"

Phrase: "explained by the specific induction of Txnip,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205263:Induction [Functional Concept]
   742   C0205369:Specific [Qualitative Concept]
   742   C0857127:induction [Therapeutic or Preventive Procedure]
   742   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C1552740:specific [Intellectual Product]
   742   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "the endogenous inhibitor of thioredoxin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205227:Endogenous [Functional Concept]
   760   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.176: Hyperglycemia enhances the thioredoxin/Txnip interaction leading to a functional inhibition of antioxidative thioredoxin function. 

Phrase: "Hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the thioredoxin/Txnip interaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0872079:protein interaction [Molecular Function]
   804   C1704675:Interaction [Functional Concept]
   722   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]

Phrase: "leading to a functional inhibition of antioxidative thioredoxin function."
Meta Candidates (Total=23; Excluded=4; Pruned=0; Remaining=19)
   762   C0021469:Inhibition, function [Molecular Function]
           Inhibition
   745   C3640044:Lead Function [Conceptual Entity]
   742   C0021467:Inhibition [Mental Process]
   742   C0031843:function [Physiologic Function]
   742   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205245:Functional [Functional Concept]
   742   C0332152:Leading [Temporal Concept]
   742   C0542341:Function [Functional Concept]
           Functional
   742   C0700205:FUNCTION [Classification]
   742   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C1522538:Leading [Functional Concept]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C1705273:Function [Intellectual Product]
   742   C2700217:Functional [Conceptual Entity]
   742   C3463820:Inhibition [Activity]
   742   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   708 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   708 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   708 E C2348269:Lead [Element, Ion, or Isotope]
   708 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.177: This specific interaction results in a shift of the cellular redox balance that promotes increased intracellular oxidative stress. 

Phrase: "This specific interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704675:Interaction [Functional Concept]

Phrase: "results in a shift of the cellular redox balance"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   742   C0007634:Cellular [Cell]
   742   C0014653:Balance [Organism Function]
   742   C0030012:Redox [Molecular Function]
   742   C0178539:Cellular [Functional Concept]
   742   C0205415:Balance [Functional Concept]
   742   C0333051:Shift [Functional Concept]
   742   C0560184:Balance [Finding]
   742   C1274040:Result [Functional Concept]
   742   C1546471:Result [Idea or Concept]
   742   C2347509:Shift [Phenomenon or Process]
   742   C2825142:Result [Finding]

Phrase: "that"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "increased intracellular oxidative stress."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   902   C0231298:Increased stress [Functional Concept]
   861   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   812   C0038435:Stress [Finding]
   812   C0311404:Oxidative [Functional Concept]
   741 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.178: While previous reports described an increased formation of ROS (9, 10), our findings demonstrate the functional inhibition of a central ROS-reducing cellular system in diabetes mellitus. 

Phrase: "While"

Phrase: "previous reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "an increased formation of ROS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "(9,"

Phrase: "10"

Phrase: ")"

Phrase: ","

Phrase: "our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "demonstrate"

Phrase: "the functional inhibition of a central ROS-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0034750:Reactive Inhibition [Individual Behavior]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "cellular system in diabetes mellitus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C2945747:diabetes system [Therapeutic or Preventive Procedure]
   760   C0449913:System [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
Processing 00000000.tx.179: A pivotal mechanism leading to oxidative stress in hyperglycemia is the increased formation of superoxide anion by the mitochondria (9). 

Phrase: "A pivotal mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "leading to oxidative stress"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]
   770   C0332152:Leading [Temporal Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "is"

Phrase: "the increased formation of superoxide anion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "by the mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.180: Superoxide anion activates several major pathways of cellular damage in hyperglycemia: the polyol pathway, increased flux through the hexosamine pathway, activation of PKC, and the formation of advanced glycation end products (3, 9). 

Phrase: "Superoxide anion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038836:Superoxide Anion [Element, Ion, or Isotope]
           Superoxide
   861   C0003075:Anion [Element, Ion, or Isotope]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "several major pathways of cellular damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]

Phrase: "in hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: ":"

Phrase: "the polyol pathway,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "increased flux through the hexosamine pathway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348693:Flux [Natural Phenomenon or Process]

Phrase: "activation of PKC,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   900   C3546691:protein kinase C activation [Molecular Function]
   844   C1819041:protein kinase activation [Cell Function]
   797   C0599177:protein activation [Genetic Function]
   760   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "the formation of advanced glycation end products"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.181: Increased mitochondrial formation of superoxide anion has been attributed to increased glycolytic production of pyruvate and NADH that in turn leads to an increase of the mitochondrial proton gradient with excess production of superoxide anion (3). 

Phrase: "Increased mitochondrial formation of superoxide anion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "attributed to increased glycolytic production of pyruvate"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   774   C0860764:pyruvate increased [Finding]
   748   C0033268:production [Occupational Activity]
   748   C0034354:pyruvate [Organic Chemical]
   748   C0205217:Increased [Quantitative Concept]
   748   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   748   C0442805:Increased [Functional Concept]
   743   C0541989:Increased Glycolysis [Molecular Function]
   738 E C2745923:Glycolysis increased [Finding]
   714   C0449234:Attribute [Idea or Concept]
   714   C1704772:Attribute [Conceptual Entity]
   714   C1882133:Attribute [Qualitative Concept]

Phrase: "and"

Phrase: "NADH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027289:NADH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "that in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "leads to an increase of the mitochondrial proton gradient"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   762   C1880999:GRADIENT INCREASE [Event]
   742   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   742   C0026237:Mitochondrial [Cell Component]
   742   C0033727:Proton [Element, Ion, or Isotope]
   742   C0181586:leads [Medical Device]
   742   C0439182:% gradient [Quantitative Concept]
   742   C0442805:Increase [Functional Concept]
   742   C0521451:Mitochondrial [Functional Concept]
   742   C0812409:Gradient [Quantitative Concept]
   742   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   742   C1522538:Lead [Functional Concept]
   742   C2348269:Lead [Element, Ion, or Isotope]
   742   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "with excess production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "of superoxide anion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038836:Superoxide Anion [Element, Ion, or Isotope]
           Superoxide
   861   C0003075:Anion [Element, Ion, or Isotope]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.182: It can be prevented by overexpression of uncoupling protein-1 (UCP-1) leading to a breakdown of the proton gradient or overexpression of superoxide dismutase leading to increased degradation of superoxide anion (9). 

Phrase: "It"

Phrase: "can"

Phrase: "be"

Phrase: "prevented by overexpression of uncoupling protein-1 (UCP-1)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0107264:uncoupling protein 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   814   C1421313:UNCOUPLING PROTEIN 1 [Gene or Genome]
   778   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   714   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "leading to a breakdown of the proton gradient"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   744   C0033727:Proton [Element, Ion, or Isotope]
   744   C0332152:Leading [Temporal Concept]
   744   C0439182:% gradient [Quantitative Concept]
   744   C0443161:break down [Qualitative Concept]
   744   C0699900:breakdown [Organism Function]
   744   C0812409:Gradient [Quantitative Concept]
   744   C1265875:breakdown [Acquired Abnormality]
   744   C1522538:Leading [Functional Concept]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "overexpression of superoxide dismutase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "leading to increased degradation of superoxide anion"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   778   C0038836:Superoxide Anion [Element, Ion, or Isotope]
           Superoxide
   757   C0861064:increased lead [Finding]
   748   C0003075:Anion [Element, Ion, or Isotope]
   748   C0205217:Increased [Quantitative Concept]
   748   C0243125:degradation [Functional Concept]
   748   C0332152:Leading [Temporal Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0699900:Degradation [Organism Function]
   748   C1522538:Leading [Functional Concept]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.183: The activation of PKC plays a role in the activation of the membrane-bound NADPH oxidase resulting in further increase of superoxide production (10). 

Phrase: "The activation of PKC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   864   C3546691:protein kinase C activation [Molecular Function]
   820   C1819041:protein kinase activation [Cell Function]
   783   C0599177:protein activation [Genetic Function]
   753   C1879547:Activation [Activity]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in the activation of the membrane-bound NADPH oxidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0035820:Role [Social Behavior]
   738   C1705810:Role [Conceptual Entity]

Phrase: "resulting in further increase of superoxide production"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   778   C0332294:Resulting in [Functional Concept]
   748   C0033268:production [Occupational Activity]
   748   C0038836:Superoxide [Element, Ion, or Isotope]
   748   C0442805:Increase [Functional Concept]
   748   C0678226:resulting [Functional Concept]
   748   C1517331:Further [Spatial Concept]
   714 E C0205108:far [Spatial Concept]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.184: Superoxide anion is also known to interact with nitric oxide (NO) producing the highly reactive metabolite peroxynitrate that in turn leads to uncoupling of endothelial NO synthase (31). 

Phrase: "Superoxide anion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038836:Superoxide Anion [Element, Ion, or Isotope]
           Superoxide
   861   C0003075:Anion [Element, Ion, or Isotope]

Phrase: "is"

Phrase: "also"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with nitric oxide (NO)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   770   C0030015:oxide [Inorganic Chemical]
   770   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "producing"

Phrase: "the highly reactive metabolite peroxynitrate"

Phrase: "that in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "leads"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C0181586:leads [Medical Device]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "uncoupling of endothelial NO synthase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   882   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   882   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   882   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   833   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   790   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0014257:Endothelial [Tissue]
   753   C0030015:oxide [Inorganic Chemical]
   753   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.185: Furthermore, uncoupling of NO synthase also occurs when this enzyme is deprived of its critical co-factor tetrahydrobiopterin or the substrate L-arginine. 

Phrase: "Furthermore,"

Phrase: "uncoupling of NO synthase also"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   790   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0030015:oxide [Inorganic Chemical]
   753   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "when"

Phrase: "this enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "deprived of its critical co-factor tetrahydrobiopterin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0048897:Tetrahydrobiopterin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C1511545:Critical [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "or"

Phrase: "the substrate L-arginine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.186: Uncoupling of endothelial NO synthase results in the production of molecular oxygen at the prosthetic heme site rather than formation of NO (31, 32). 

Phrase: "Uncoupling of endothelial NO synthase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   882   C0669365:Nitric Oxide Synthase, Endothelial [Amino Acid, Peptide, or Protein,Enzyme]
   882   C0907532:Endothelial Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   882   C1328053:NITRIC OXIDE SYNTHASE, ENDOTHELIAL [Gene or Genome]
   833   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   790   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0014257:Endothelial [Tissue]
   753   C0030015:oxide [Inorganic Chemical]
   753   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "results in the production of molecular oxygen"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0302920:Molecular oxygen [Element, Ion, or Isotope]
   748   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0033268:production [Occupational Activity]
   748   C1274040:Result [Functional Concept]
   748   C1521991:Molecular [Qualitative Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "at the prosthetic heme site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "rather than"

Phrase: "formation of NO"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   881   C1157570:nitric oxide formation [Molecular Function]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.187: Based on the experimental results of the present study, additional mechanisms might also contribute to increased levels of hydrogen peroxide in hyperglycemia. 

Phrase: "Based on the experimental results of the present study,"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   762   C0681814:experimental study [Research Activity]
   762   C0683954:results study [Finding]
   742   C0150312:Present [Quantitative Concept]
   742   C0449450:Present [Idea or Concept]
   742   C0557651:Study [Manufactured Object]
   742   C1517586:Experimental [Qualitative Concept]
   742   C1527178:Based [Functional Concept]
   742   C1705938:Based [Idea or Concept]
   742   C2603343:Study [Research Activity]
   731   C2825142:Experimental Result [Finding]
           Result
   708 E C0002055:base [Inorganic Chemical]
   708 E C0178499:Base [Chemical Viewed Functionally]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708 E C1880279:Base [Biomedical or Dental Material]

Phrase: "additional mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "might"

Phrase: "also"

Phrase: "contribute to increased levels of hydrogen peroxide"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0020275:Hydrogen [Element, Ion, or Isotope]
   748   C0031180:Peroxide [Inorganic Chemical]
   748   C0205217:Increased [Quantitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0523702:HYDROGEN [Laboratory Procedure]
   748   C0885426:hydrogen [Inorganic Chemical]
   748   C1880177:Contribute [Activity]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in hyperglycemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]
Processing 00000000.tx.188: Gene silencing of Txnip prevented reduction of thioredoxin activity and reduces intracellular levels of ROS in hyperglycemia. 

Phrase: "Gene silencing of Txnip"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0598496:Gene Silencing [Genetic Function]
   783   C0751455:gene protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1336690:Thioredoxin Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   719   C0858952:silence [Mental or Behavioral Dysfunction]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "reduction of thioredoxin activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C2267000:Reduction Activity [Molecular Function]
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "reduces"

Phrase: "intracellular levels of ROS"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in hyperglycemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]
Processing 00000000.tx.189: Notably, adenoviral overexpression of thioredoxin reduces hyperglycemia-induced levels of ROS, while overexpression of Txnip enhances oxidative stress. 

Phrase: "Notably,"

Phrase: "adenoviral overexpression of thioredoxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "reduces"

Phrase: "hyperglycemia-induced levels of ROS,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "while"

Phrase: "overexpression of Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.190: Gene knockdown of Txnip reduced the hyperglycemia-induced increase in oxidative stress compared with controls without significant differences at base line. 

Phrase: "Gene knockdown of Txnip"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2350567:Gene Knock-Down [Molecular Biology Research Technique]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the hyperglycemia-induced increase in oxidative stress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "without significant differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "at base line."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0168634:baseline [Biomedical or Dental Material]
  1000   C1442488:Baseline [Quantitative Concept]
   861   C0002055:base [Inorganic Chemical]
   861   C0178499:Base [Chemical Viewed Functionally]
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1880279:Base [Biomedical or Dental Material]
   789 E C0205112:Basal [Spatial Concept]
   777 E C0016617:Foundation [Organization]
   777 E C1626935:Bases [Quantitative Concept]
Processing 00000000.tx.191: However, hyperglycemia still increases levels of hydrogen peroxide in cells transfected with Txnip RNAi as measured by the cell-permeable and redox-sensitive compound DCFDA that interacts rather specifically with hydrogen peroxide. 

Phrase: "However,"

Phrase: "hyperglycemia still"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "levels of hydrogen peroxide"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with Txnip RNAi"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1136031:RNAi [Genetic Function]
   753   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "as"

Phrase: "measured by the cell-permeable"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0007634:Cell [Cell]
   760   C0205326:Permeable [Functional Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "redox-sensitive compound DCFDA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0369114:Diacetate [Organic Chemical]

Phrase: "that"

Phrase: "interacts"

Phrase: "rather specifically with hydrogen peroxide."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0020275:Hydrogen [Element, Ion, or Isotope]
   760   C0031180:Peroxide [Inorganic Chemical]
   760   C0523702:HYDROGEN [Laboratory Procedure]
   760   C0885426:hydrogen [Inorganic Chemical]
Processing 00000000.tx.192: This increase might reflect levels of reactive oxygen species that overwhelm the scavenging capacity of the thioredoxin system even in the absence of the endogenous inhibitor Txnip. 

Phrase: "This increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "might"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "levels of reactive oxygen species"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "overwhelm"

Phrase: "the scavenging capacity of the thioredoxin system even"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1516240:Capacity [Quantitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of the endogenous inhibitor Txnip."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.193: Notably, superoxide dismustase, glutathione peroxidase, and catalase, all central enzymes in the antioxidative defense mechanisms of the cell, are induced under hyperglycemic conditions, most probably reflecting a counter-regulatory mechanism of the cell (33). 

Phrase: "Notably,"

Phrase: "superoxide dismustase,"

Phrase: "glutathione peroxidase,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0017822:GLUTATHIONE PEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415275:GLUTATHIONE PEROXIDASE [Gene or Genome]
   861   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "catalase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "all central enzymes in the antioxidative defense mechanisms of the cell,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0014442:Enzymes [Enzyme,Organic Chemical]
   738   C0014445:enzymes [Functional Concept]
   721   C0596524:enzyme mechanism [Molecular Function]

Phrase: "are"

Phrase: "induced under hyperglycemic conditions,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205263:Induced [Functional Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "most probably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205393:Most [Quantitative Concept]
   861   C0750492:Probably [Idea or Concept]

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "a counter-regulatory mechanism of the cell"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.194: In addition, increased levels of hydrogen peroxide that result from impaired scavenging by thioredoxin are known to inhibit the Cu,Zn-superoxide dismutase activity (34) and activate NADPH oxidase (35). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "increased levels of hydrogen peroxide"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "that result from impaired scavenging"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "by thioredoxin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the Cu,Zn-superoxide dismutase activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C2611757:Cu-Zn superoxide dismutase activity [Molecular Function]
   884   C1151619:superoxide dismutase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0010461:Cu-Zn Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme]
   722   C0010434:Cu-Superoxide Dismutase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(34"

Phrase: ")"

Phrase: "and"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "NADPH oxidase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0068355:NADPH Oxidase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1151146:NADPH oxidase [Molecular Function]
   861   C0027303:NADPH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.195: These mechanisms could in turn lead to an ambient increase of superoxide anion. 

Phrase: "These mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "could"

Phrase: "in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "lead to an ambient increase of superoxide anion."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0038836:Superoxide Anion [Element, Ion, or Isotope]
           Superoxide
   744   C0003075:Anion [Element, Ion, or Isotope]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0442805:Increase [Functional Concept]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C1879688:Ambient [Qualitative Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.196: Therefore, the induction of Txnip in hyperglycemia represents a unique molecular switch mechanism that results in a reduced scavenging capacity of the antioxidative thioredoxin system leading to increased oxidative stress. 

Phrase: "Therefore,"

Phrase: "the induction of Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "in hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a unique molecular switch mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0441712:Mechanism [Functional Concept]
   812   C1706376:Mechanism [Manufactured Object]

Phrase: "that results in a reduced scavenging capacity of the antioxidative thioredoxin system"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   703   C1274040:Result [Functional Concept]
   703   C1546471:Result [Idea or Concept]
   703   C2825142:Result [Finding]

Phrase: "leading to increased oxidative stress."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   806   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   797   C0231298:Increased stress [Functional Concept]
   781   C0861064:increased lead [Finding]
   760   C0038435:Stress [Finding]
   760   C0205217:Increased [Quantitative Concept]
   760   C0311404:Oxidative [Functional Concept]
   760   C0332152:Leading [Temporal Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1522538:Leading [Functional Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.197: The PI 3-kinase/Akt pathway negatively regulates the transcriptional activation of Txnip, while activation of p38 MAPK represents a necessary step in the increased expression of Txnip in hyperglycemia. 

Phrase: "The PI 3-kinase/Akt pathway negatively"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1704259:Pathway [Molecular Function]
   799   C1705987:Pathway [Conceptual Entity]

Phrase: "regulates"

Phrase: "the transcriptional activation of Txnip,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0162493:Transcriptional Activation [Genetic Function]
   774   C0599177:protein activation [Genetic Function]
   748   C1879547:Activation [Activity]

Phrase: "while"

Phrase: "activation of p38 MAPK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1155551:MAPK activation [Molecular Function]
   770   C1879547:Activation [Activity]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a necessary step in"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1261552:Step [Conceptual Entity]
   827   C1704379:Step [Functional Concept]
   827   C1705117:Step [Quantitative Concept]
   827   C2825408:Step [Manufactured Object]

Phrase: "the increased expression of Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in hyperglycemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]
Processing 00000000.tx.198: Hyperglycemia inhibits activation of Akt; 

Phrase: "Hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "activation of Akt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: ";"
Processing 00000000.tx.199: however, we can only speculate about the potential mechanisms of reduced activity of the PI 3-kinase/Akt pathway in hyperglycemia. 

Phrase: "however,"

Phrase: "we"

Phrase: "can"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "speculate about the potential mechanisms of reduced activity"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0086439:Reduced Activity [Sign or Symptom]
   744   C0205177:Activity [Functional Concept]
   744   C0392756:Reduced [Qualitative Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0441712:Mechanisms [Functional Concept]
   744   C1561536:*Activity [Idea or Concept]
   744   C3245505:Potential [Qualitative Concept]
   711 E C1706376:Mechanism [Manufactured Object]

Phrase: "of the PI 3-kinase/Akt pathway"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1704259:Pathway [Molecular Function]
   804   C1705987:Pathway [Conceptual Entity]
   717   C0044602:PI 3 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0919338:PI-3 kinase [Gene or Genome]
   717   C2936824:PI-3 Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in hyperglycemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]
Processing 00000000.tx.200: One possible candidate for reduced Akt activity in hyperglycemia is the mammalian homolog of Drosophila tribbles, which functions as a negative modulator of Akt (36). 

Phrase: "One possible candidate for reduced Akt activity"

Phrase: "in hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "is"

Phrase: "the mammalian homolog of Drosophila tribbles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1334043:Homolog [Gene or Genome]

Phrase: "which"

Phrase: "functions as a negative modulator of Akt"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0031843:function [Physiologic Function]
   748   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205160:Negative [Qualitative Concept]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C0812228:AKT [Gene or Genome]
   748   C1513916:Negative [Finding]
   748   C1705273:Function [Intellectual Product]
   748   C1709060:Modulator [Manufactured Object]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.201: By directly binding to Akt, TRB3 blocks the activation of this kinase. 

Phrase: "By directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "binding to Akt,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   858   C1624020:Akt binding [Molecular Function]
   790   C0164786:AKT [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0243122:binding [Functional Concept]
   790   C0812228:AKT [Gene or Genome]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "TRB3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1423053:TRB3 [Gene or Genome]
  1000   C1540055:TRB3 [Gene or Genome]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the activation of this kinase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]
Processing 00000000.tx.202: The induction of Txnip in hyperglycemia is not restricted to vascular tissue. 

Phrase: "The induction of Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "in hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "restricted to vascular tissue."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   805   C1511228:Blood Vessel Tissue [Tissue]
       E   VESSEL, BLOOD
   770   C0005847:vascular [Body Part, Organ, or Organ Component]
   770   C0040300:Tissue [Tissue]
   770   C0443288:Restricted [Functional Concept]
   770   C1547928:Tissue [Intellectual Product]
   770   C1558950:VASCULAR [Finding]
   770   C1801960:Vascular [Qualitative Concept]
   715 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
Processing 00000000.tx.203: Through transcriptional screening of glucose-induced gene expression, Txnip has been identified as one of the genes with the highest induction in response to glucose incubation in fibroblasts (37), islet cells (38), and mesangial cells (39). 

Phrase: "Through transcriptional screening"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0220908:Screening [Health Care Activity]
   861   C0220909:screening [Functional Concept]
   861   C1698960:screening [Intellectual Product]
   861   C1710031:Screening [Diagnostic Procedure]
   861   C1710477:SCREENING [Research Activity]

Phrase: "of glucose-induced gene expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0017262:Gene Expression [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "identified as one of the genes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017337:Genes [Gene or Genome]
   753   C0205396:Identified [Qualitative Concept]
   753   C0205447:One [Quantitative Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]

Phrase: "with the highest induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205263:Induction [Functional Concept]
   861   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to glucose incubation"

Phrase: "in fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "(37"

Phrase: ")"

Phrase: ","

Phrase: "islet cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   966 E C1522529:Islet Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(38"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "mesangial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0227651:Mesangial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.204: Moreover, increased renal expression of Txnip was demonstrated recently in an animal model of STZ-induced diabetes mellitus (39). 

Phrase: "Moreover,"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "renal expression of Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "demonstrated"

Phrase: "recently in an animal model of STZ-induced diabetes mellitus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   760   C0599779:Animal Model [Animal]
   739   C0003062:Animal [Animal]
   739   C0011847:Diabetes [Disease or Syndrome]
   739   C0038432:STZ [Antibiotic,Carbohydrate]
   739   C0205263:Induced [Functional Concept]
   739   C0332185:Recently [Temporal Concept]
   739   C1539862:STZ [Gene or Genome]
   739   C3161035:Model [Intellectual Product]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.205: The induction of Txnip by glucose seems to be a sustained effect and can be detected up to 36 h after stimulation in mesangial cells (39). 

Phrase: "The induction of Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a sustained effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "can"

Phrase: "be"

Phrase: "detected up to 36 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0442726:Detected [Finding]
   760   C0564385:/h [Quantitative Concept]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "after stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in mesangial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0227651:Mesangial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.206: Our experimental findings suggest a direct and concentration-dependent regulation of Txnip by glucose in hyperglycemia. 

Phrase: "Our experimental findings"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   983   C2825141:Experimental Finding [Finding]
       E   Finding
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "concentration-dependent regulation of Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "by glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "in hyperglycemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]
Processing 00000000.tx.207: In addition to its ROS promoting effects leading to oxidative stress, Txnip may also play a crucial role in reducing cellular viability in hyperglycemia by sensitizing cell toward apoptosis (13). 

Phrase: "In addition to its ROS promoting effects"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C1280500:effects [Qualitative Concept]
   771 E C2348382:Effect [Qualitative Concept]
   717   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "leading to oxidative stress,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]
   770   C0332152:Leading [Temporal Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "Txnip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "also"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a crucial role in reducing cellular viability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "by sensitizing cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "toward apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.208: Therefore, this recently discovered gene product may have diverse effects with broad pathophysiological implications in the development of end-organ damage in diabetes mellitus.  

Phrase: "Therefore,"

Phrase: "this recently discovered gene product"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0017337:Gene [Gene or Genome]
   812   C1514468:product [Entity]
   812   C1704444:Product [Quantitative Concept]

Phrase: "may"

Phrase: "have"

Phrase: "diverse effects with broad pathophysiological implications"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "in the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of end-organ damage"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0743496:end organ damage [Disease or Syndrome]
   827   C0010957:Damage [Injury or Poisoning]
   827   C0178784:Organ [Body Part, Organ, or Organ Component]
   827   C0444930:End [Spatial Concept]
   827   C1883709:Damage [Functional Concept]
   827   C2746065:End [Temporal Concept]
   771 E C0205088:Terminal [Temporal Concept]
   771 E C1705314:Terminal [Manufactured Object]
   771 E C1705315:Terminal [Spatial Concept]

Phrase: "in diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]
Processing 00000000.tx.209: FOOTNOTES  * This work was supported by grants from the NHLBI, National Institutes of Health, the Deutsche Akademie der Naturforscher Leopoldina (to P. C. S.), and the Banyu-Merck Fellowship in Cardiovascular Medicine (to T. T.). 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the NHLBI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1955970:NHLBI [Health Care Related Organization]

Phrase: "National Institutes of Health,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "the Deutsche Akademie der Naturforscher Leopoldina"

Phrase: "("

Phrase: "to P. C."

Phrase: "S."

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the Banyu-Merck Fellowship in Cardiovascular Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0015770:Fellowship [Educational Activity]

Phrase: "("

Phrase: "to T. T."

Phrase: ")."
Processing 00000000.tx.210: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.211: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.212: Section 1734 solely to indicate this fact.  

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.213: To whom correspondence should be addressed: Cardiovascular Division, Brigham and Women's Hospital, 65 Landsdowne St., Cambridge, MA 02139. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Cardiovascular Division,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1293097:Division [Therapeutic or Preventive Procedure]
   861   C2919030:Division [Organization]
   861   C2919031:Division [Activity]

Phrase: "Brigham and Women's Hospital,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C0043210:Women [Population Group]
   812   C1510665:Hospital [Qualitative Concept]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "65 Landsdowne St., Cambridge,"

Phrase: "MA 02139."
Processing 00000000.tx.214: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.215: 617-768-8272; 

Phrase: "617-768-8272"

Phrase: ";"
Processing 00000000.tx.216: Fax: 617-768-8270; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "617-768-8270"

Phrase: ";"
Processing 00000000.tx.217: E-mail: rlee{at}rics.bwh.harvard.edu . 1 The abbreviations used are: ROS, reactive oxygen species; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "rlee{at}rics.bwh.harvard.edu . 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
   795   C1837895:RICS [Gene or Genome]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "ROS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "reactive oxygen species"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.218: Txnip, thioredoxin-interacting protein; 

Phrase: "Txnip,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "thioredoxin-interacting protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424661:THIOREDOXIN-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.219: SMC, smooth muscle cell; 

Phrase: "SMC,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021665:SM-C [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167267:SMC [Cell Component]
  1000   C1539322:SMC [Gene or Genome]
  1000   C1846431:SMC [Disease or Syndrome]

Phrase: "smooth muscle cell"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1135918:Smooth muscle cell [Cell]
   901   C0596981:Muscle cell [Cell]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0007634:Cell [Cell]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.220: PDGF, platelet-derived growth factor; 

Phrase: "PDGF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032200:PDGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "platelet-derived growth factor"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0005821:Platelet [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   812   C3245521:derived [Idea or Concept]
   729 E C1963076:Platelets [Finding]

Phrase: ";"
Processing 00000000.tx.221: MAPK, mitogen-activated protein kinase; 

Phrase: "MAPK,"

Phrase: "mitogen-activated protein kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: ";"
Processing 00000000.tx.222: RNAi, small interfering RNA; 

Phrase: "RNAi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1136031:RNAi [Genetic Function]

Phrase: "small interfering RNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0521102:interfering [Qualitative Concept]
   827   C0700321:Small [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.223: DCFDA, 2',7'-dichlorodihydrofluorecein diacetate; 

Phrase: "DCFDA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0369114:Diacetate [Organic Chemical]

Phrase: "2',"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "7'-dichlorodihydrofluorecein diacetate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0369114:Diacetate [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.224: DHE, dihydroethidium bromide; 

Phrase: "DHE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006222:Bromide [Inorganic Chemical]

Phrase: "dihydroethidium bromide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006222:Bromide [Inorganic Chemical]

Phrase: ";"
Processing 00000000.tx.225: STZ, streptozotocin; 

Phrase: "STZ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038432:STZ [Antibiotic,Carbohydrate]
  1000   C1539862:STZ [Gene or Genome]

Phrase: "streptozotocin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: ";"
Processing 00000000.tx.226: Ad, adenovirus; 

Phrase: "Ad,"

Phrase: "adenovirus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001483:Adenovirus, NOS [Virus]
  1000   C0001486:Adenovirus [Disease or Syndrome]
  1000   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.227: GFP, green fluorescent protein; 

Phrase: "GFP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "green fluorescent protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.228: PI, phosphatidylinositol; 

Phrase: "PI,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0429863:PI [Clinical Attribute]
  1000   C3537219:PI [Gene or Genome]
  1000   C3539772:PI [Intellectual Product]

Phrase: "phosphatidylinositol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
  1000   C2348046:Phosphatidylinositol [Lipid]

Phrase: ";"
Processing 00000000.tx.229: PKC, protein kinase C; 

Phrase: "PKC,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.230: Trx, thioredoxin.  

Phrase: "Trx,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "thioredoxin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.231: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Rosen, P., Nawroth, P. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Rosen,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Nawroth,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.232: P., King, G., Moller, W., Tritschler, H. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "King,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Moller,"

Phrase: "W.,"

Phrase: "Tritschler,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.233: J., and Packer, L. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Packer,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.234: (2001) Diabetes Metab. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Diabetes Metab."
Processing 00000000.tx.235: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.236: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.237: 17, 189212[CrossRef][Medline] [OrderarticleviaInfotrieve] Park, L., Raman, K. 

Phrase: "17,"

Phrase: "189212"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Raman,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0445586:Rama [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.238: G., Lee, K. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lee,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.239: J., Lu, Y., Ferran, L. 

Phrase: "J.,"

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "Y.,"

Phrase: "Ferran,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.240: J., Jr., Chow, W. 

Phrase: "J.,"

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Chow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324335:chow [Mammal]

Phrase: "W."
Processing 00000000.tx.241: S., Stern, D., and Schmidt, A. 

Phrase: "S."

Phrase: ","

Phrase: "Stern,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Schmidt,"

Phrase: "A."
Processing 00000000.tx.242: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.243: (1998) Nat. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.244: Med. 

Phrase: "Med."
Processing 00000000.tx.245: 4, 10251031[CrossRef][Medline] [OrderarticleviaInfotrieve] Brownlee, M. 

Phrase: "4,"

Phrase: "10251031"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Brownlee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.246: (2001) Nature 414, 813820[CrossRef][Medline] [OrderarticleviaInfotrieve] Suh, Y. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Nature 414,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "813820"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Suh,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416171:SUH [Gene or Genome]
  1000   C1422188:SUH [Gene or Genome]

Phrase: "Y."
Processing 00000000.tx.247: A., Arnold, R. 

Phrase: "A.,"

Phrase: "Arnold,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.248: S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A. 

Phrase: "S."

Phrase: ","

Phrase: "Lassegue,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Shi,"

Phrase: "J.,"

Phrase: "Xu,"

Phrase: "X.,"

Phrase: "Sorescu,"

Phrase: "D."

Phrase: ","

Phrase: "Chung,"

Phrase: "A."
Processing 00000000.tx.249: B., Griendling, K. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Griendling,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.250: K., and Lambeth, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Lambeth,"

Phrase: "J."
Processing 00000000.tx.251: D. 

Phrase: "D."
Processing 00000000.tx.252: (1999) Nature 401, 7982[CrossRef][Medline] [OrderarticleviaInfotrieve] Griendling, K. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 401,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "7982"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Griendling,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.253: K., Sorescu, D., Lassegue, B., and Ushio-Fukai, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sorescu,"

Phrase: "D."

Phrase: ","

Phrase: "Lassegue,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Ushio-Fukai,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.254: (2002) Arterioscler. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Arterioscler."
Processing 00000000.tx.255: Thromb. 

Phrase: "Thromb."
Processing 00000000.tx.256: Vasc. 

Phrase: "Vasc."
Processing 00000000.tx.257: Biol. 

Phrase: "Biol."
Processing 00000000.tx.258: 20, 21752183 Sundaresan, M., Yu, Z. 

Phrase: "20,"

Phrase: "21752183 Sundaresan,"

Phrase: "M."

Phrase: ","

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "Z."
Processing 00000000.tx.259: X., Ferrans, V. 

Phrase: "X.,"

Phrase: "Ferrans,"

Phrase: "V."
Processing 00000000.tx.260: J., Irani, K., and Finkel, T. 

Phrase: "J.,"

Phrase: "Irani,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337811:Irani [Population Group]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Finkel,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.261: (1995) Science 270, 296299[Abstract] Prieto-Alamo, M. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Science 270,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "296299"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Prieto-Alamo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.262: J., Jurado, J., Gallardo-Madueno, R., Monje-Casas, F., Holmgren, A., and Pueyo, C. 

Phrase: "J.,"

Phrase: "Jurado,"

Phrase: "J.,"

Phrase: "Gallardo-Madueno,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Monje-Casas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1384511:CASA [Gene or Genome]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Holmgren,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Pueyo,"

Phrase: "C."
Processing 00000000.tx.263: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.264: Biol. 

Phrase: "Biol."
Processing 00000000.tx.265: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.266: 275, 1339813405[Abstract/Free FullText] Nordberg, J., and Arner, E. 

Phrase: "275,"

Phrase: "1339813405"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nordberg,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Arner,"

Phrase: "E."
Processing 00000000.tx.267: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.268: (2001) Free Radic. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.269: Biol. 

Phrase: "Biol."
Processing 00000000.tx.270: Med. 

Phrase: "Med."
Processing 00000000.tx.271: 31, 12871312[CrossRef][Medline] [OrderarticleviaInfotrieve] Nishikawa, T., Edelstein, D., Du, X. 

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "12871312"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Nishikawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Edelstein,"

Phrase: "D."

Phrase: ","

Phrase: "Du,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540681:DU [Idea or Concept]

Phrase: "X."
Processing 00000000.tx.272: L., Yamagishi, S., Matsumura, T., Kaneda, Y., Yorek, M. 

Phrase: "L., Yamagishi,"

Phrase: "S."

Phrase: ","

Phrase: "Matsumura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kaneda,"

Phrase: "Y.,"

Phrase: "Yorek,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.273: A., Beebe, D., Oates, P. 

Phrase: "A.,"

Phrase: "Beebe,"

Phrase: "D."

Phrase: ","

Phrase: "Oates,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.274: J., Hammes, H. 

Phrase: "J.,"

Phrase: "Hammes,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.275: P., Giardino, I., and Brownlee, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Giardino,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Brownlee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.276: (2000) Nature 404, 787790[CrossRef][Medline] [OrderarticleviaInfotrieve] Inoguchi, T., Li, P., Umeda, F., Yu, H. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nature 404,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "787790"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Inoguchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Umeda,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.277: Y., Kakimoto, M., Imamura, M., Aoki, T., Etoh, T., Hashimoto, T., Naruse, M., Sano, H., Utsumi, H., and Nawata, H. 

Phrase: "Y.,"

Phrase: "Kakimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Imamura,"

Phrase: "M."

Phrase: ","

Phrase: "Aoki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Etoh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001962:ETOH [Organic Chemical]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hashimoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Naruse,"

Phrase: "M."

Phrase: ","

Phrase: "Sano,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Utsumi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Nawata,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.278: (2000) Diabetes 49, 19391945[Abstract] Holmgren, A. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Diabetes 49,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "19391945"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Holmgren,"

Phrase: "A."
Processing 00000000.tx.279: (1985) Annu. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.280: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.281: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.282: 54, 237271[CrossRef][Medline] [OrderarticleviaInfotrieve] Griendling, K. 

Phrase: "54,"

Phrase: "237271"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Griendling,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.283: K., and Alexander, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Alexander,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551702:Alexander [Population Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.284: W. 

Phrase: "W."
Processing 00000000.tx.285: (1997) Circulation 96, 32643265[Medline] [OrderarticleviaInfotrieve] Wang, Y., De Keulenaer, G. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Circulation 96,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: "32643265"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wang,"

Phrase: "Y.,"

Phrase: "De Keulenaer,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.286: W., and Lee, R. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.287: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.288: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.289: Biol. 

Phrase: "Biol."
Processing 00000000.tx.290: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.291: 277, 2649626500[Abstract/Free FullText] Schulze, P. 

Phrase: "277,"

Phrase: "2649626500"

Phrase: "[Abstract/Free FullText"

Phrase: "] Schulze,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.292: C., De Keulenaer, G. 

Phrase: "C., De Keulenaer,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.293: W., Yoshioka, J., Kassik, K. 

Phrase: "W., Yoshioka,"

Phrase: "J.,"

Phrase: "Kassik,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.294: A., and Lee, R. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.295: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.296: (2002) Circ. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Circ."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332520:Circ [Quantitative Concept]
  1000   C2347774:circ [Quantitative Concept]
Processing 00000000.tx.297: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.298: 91, 689695[Abstract/Free FullText] Nishiyama, A., Matsui, M., Iwata, S., Hirota, K., Masutani, H., Nakamura, H., Takagi, Y., Sono, H., Gon, Y., and Yodoi, J. 

Phrase: "91,"

Phrase: "689695"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nishiyama,"

Phrase: "A.,"

Phrase: "Matsui,"

Phrase: "M."

Phrase: ","

Phrase: "Iwata,"

Phrase: "S."

Phrase: ","

Phrase: "Hirota,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Masutani,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nakamura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Takagi,"

Phrase: "Y.,"

Phrase: "Sono,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Gon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551057:Gon [Quantitative Concept]

Phrase: "Y.,"

Phrase: "and"

Phrase: "Yodoi,"

Phrase: "J."
Processing 00000000.tx.299: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.300: Biol. 

Phrase: "Biol."
Processing 00000000.tx.301: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.302: 274, 2164521650[Abstract/Free FullText] Junn, E., Han, S. 

Phrase: "274,"

Phrase: "2164521650"

Phrase: "[Abstract/Free FullText"

Phrase: "] Junn,"

Phrase: "E.,"

Phrase: "Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.303: H., Im, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Im,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539078:IM [Idea or Concept]

Phrase: "J."
Processing 00000000.tx.304: Y., Yang, Y., Cho, E. 

Phrase: "Y.,"

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "Y.,"

Phrase: "Cho,"

Phrase: "E."
Processing 00000000.tx.305: W., Um, H. 

Phrase: "W., Um,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.306: D., Kim, D. 

Phrase: "D."

Phrase: ","

Phrase: "Kim,"

Phrase: "D."
Processing 00000000.tx.307: K., Lee, K. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.308: W., Han, P. 

Phrase: "W., Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1551910:Han [Language]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.309: L., Rhee, S. 

Phrase: "L., Rhee,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.310: G., and Choi, I. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Choi,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.311: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.312: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.313: 164, 62876295[Abstract/Free FullText] Way, K. 

Phrase: "164,"

Phrase: "62876295"

Phrase: "[Abstract/Free FullText"

Phrase: "] Way,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.314: J., Katai, N., and King, G. 

Phrase: "J.,"

Phrase: "Katai,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "King,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.315: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.316: (2001) Diabet. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Diabet."
Processing 00000000.tx.317: Med. 

Phrase: "Med."
Processing 00000000.tx.318: 18, 945959[CrossRef][Medline] [OrderarticleviaInfotrieve] Federici, M., Menghini, R., Mauriello, A., Hribal, M. 

Phrase: "18,"

Phrase: "945959"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Federici,"

Phrase: "M."

Phrase: ","

Phrase: "Menghini,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mauriello,"

Phrase: "A.,"

Phrase: "Hribal,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.319: L., Ferrelli, F., Lauro, D., Sbraccia, P., Spagnoli, L. 

Phrase: "L., Ferrelli,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Lauro,"

Phrase: "D."

Phrase: ","

Phrase: "Sbraccia,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Spagnoli,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.320: G., Sesti, G., and Lauro, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Sesti,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Lauro,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.321: (2002) Circulation 106, 466472[Abstract/Free FullText] Zhao, H., Kalivendi, S., Zhang, H., Joseph, J., Nithipatikom, K., Vasquez-Vivar, J., and Kalyanaraman, B. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Circulation 106,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: "466472"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhao,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kalivendi,"

Phrase: "S."

Phrase: ","

Phrase: "Zhang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Joseph,"

Phrase: "J.,"

Phrase: "Nithipatikom,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Vasquez-Vivar,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Kalyanaraman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.322: (2003) Free Radic. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.323: Biol. 

Phrase: "Biol."
Processing 00000000.tx.324: Med. 

Phrase: "Med."
Processing 00000000.tx.325: 34, 13591368[CrossRef][Medline] [OrderarticleviaInfotrieve] Szcs, K., Lassegue, B., Sorescu, D., Hilenski, L. 

Phrase: "34,"

Phrase: "13591368"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Szcs,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lassegue,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Sorescu,"

Phrase: "D."

Phrase: ","

Phrase: "Hilenski,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.326: L., Valppu, L., Couse, T. 

Phrase: "L., Valppu,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Couse,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.327: L., Wolcox, J. 

Phrase: "L., Wolcox,"

Phrase: "J."
Processing 00000000.tx.328: N., Quinn, M. 

Phrase: "N., Quinn,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.329: T., Lambeth, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Lambeth,"

Phrase: "J."
Processing 00000000.tx.330: D., and Griendling, K. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Griendling,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.331: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.332: (2002) Arterioscler. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Arterioscler."
Processing 00000000.tx.333: Thromb. 

Phrase: "Thromb."
Processing 00000000.tx.334: Vasc. 

Phrase: "Vasc."
Processing 00000000.tx.335: Biol. 

Phrase: "Biol."
Processing 00000000.tx.336: 22, 2127[Abstract/Free FullText] Munzel, T., Afanas'ev, I. 

Phrase: "22,"

Phrase: "2127"

Phrase: "[Abstract/Free FullText"

Phrase: "] Munzel,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Afanas'ev,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014522:EV [Neoplastic Process]
   861   C0560135:eV [Quantitative Concept]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.337: B., Kleschyov, A. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kleschyov,"

Phrase: "A."
Processing 00000000.tx.338: L., and Harrison, D. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Harrison,"

Phrase: "D."
Processing 00000000.tx.339: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.340: (2002) Arterioscler. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Arterioscler."
Processing 00000000.tx.341: Thromb. 

Phrase: "Thromb."
Processing 00000000.tx.342: Vasc. 

Phrase: "Vasc."
Processing 00000000.tx.343: Biol. 

Phrase: "Biol."
Processing 00000000.tx.344: 22, 17611768[Abstract/Free FullText] Matsui, M., Oshima, M., Oshima, H., Takaku, K., Maruyama, T., Yodoi, J., and Taketo, M. 

Phrase: "22,"

Phrase: "17611768"

Phrase: "[Abstract/Free FullText"

Phrase: "] Matsui,"

Phrase: "M."

Phrase: ","

Phrase: "Oshima,"

Phrase: "M."

Phrase: ","

Phrase: "Oshima,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Takaku,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Maruyama,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yodoi,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Taketo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.345: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.346: (1996) Dev. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Dev."
Processing 00000000.tx.347: Biol. 

Phrase: "Biol."
Processing 00000000.tx.348: 178, 179185[CrossRef][Medline] [OrderarticleviaInfotrieve] Kanzok, S. 

Phrase: "178,"

Phrase: "179185"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kanzok,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.349: M., Fechner, A., Bauer, H., Ulschmid, J. 

Phrase: "M."

Phrase: ","

Phrase: "Fechner,"

Phrase: "A.,"

Phrase: "Bauer,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ulschmid,"

Phrase: "J."
Processing 00000000.tx.350: K., Muller, H. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Muller,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.351: M., Botella-Munoz, J., Schneuwly, S., Schirmer, R., and Becker, K. 

Phrase: "M."

Phrase: ","

Phrase: "Botella-Munoz,"

Phrase: "J.,"

Phrase: "Schneuwly,"

Phrase: "S."

Phrase: ","

Phrase: "Schirmer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1875738:SCHIRMER [Medical Device]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Becker,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.352: (2001) Science 291, 643646[Abstract/Free FullText] Haendeler, J., Hoffmann, J., Tischler, V., Berk, B. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Science 291,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "643646"

Phrase: "[Abstract/Free FullText"

Phrase: "] Haendeler,"

Phrase: "J.,"

Phrase: "Hoffmann,"

Phrase: "J.,"

Phrase: "Tischler,"

Phrase: "V.,"

Phrase: "Berk,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.353: C., Zeiher, A. 

Phrase: "C., Zeiher,"

Phrase: "A."
Processing 00000000.tx.354: M., and Dimmeler, S. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Dimmeler,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.355: (2002) Nat. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.356: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.357: 4, 743749[CrossRef][Medline] [OrderarticleviaInfotrieve] Schenk, H., Klein, M., Erdbrgger, W., Drge, W., and Schulze-Osthoff, K. 

Phrase: "4,"

Phrase: "743749"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Schenk,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Klein,"

Phrase: "M."

Phrase: ","

Phrase: "Erdbrgger,"

Phrase: "W.,"

Phrase: "Drge,"

Phrase: "W.,"

Phrase: "and"

Phrase: "Schulze-Osthoff,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.358: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.359: Nat. 

Phrase: "Nat."
Processing 00000000.tx.360: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.361: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.362: U. 

Phrase: "U."
Processing 00000000.tx.363: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.364: A. 

Phrase: "A."
Processing 00000000.tx.365: 91, 16721676[Abstract] Hirota, K., Murata, M., Sachi, Y., Nakamura, H., Takeuchi, J., Mori, K., and Yodoi, J. 

Phrase: "91,"

Phrase: "16721676"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hirota,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Murata,"

Phrase: "M."

Phrase: ","

Phrase: "Sachi,"

Phrase: "Y.,"

Phrase: "Nakamura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Takeuchi,"

Phrase: "J.,"

Phrase: "Mori,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Yodoi,"

Phrase: "J."
Processing 00000000.tx.366: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.367: Biol. 

Phrase: "Biol."
Processing 00000000.tx.368: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.369: 274, 2789127897[Abstract/Free FullText] Pekkari, K., Avila-Carino, J., Gurunath, R., Bengtsson, A., Scheynius, A., and Holmgren, A. 

Phrase: "274,"

Phrase: "2789127897"

Phrase: "[Abstract/Free FullText"

Phrase: "] Pekkari,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Avila-Carino,"

Phrase: "J.,"

Phrase: "Gurunath,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bengtsson,"

Phrase: "A.,"

Phrase: "Scheynius,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Holmgren,"

Phrase: "A."
Processing 00000000.tx.370: (2003) FEBS Lett. 

Phrase: "(2003"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.371: 539, 143148[CrossRef][Medline] [OrderarticleviaInfotrieve] Tanudji, M., Hevi, S., and Chuck, S. 

Phrase: "539,"

Phrase: "143148"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tanudji,"

Phrase: "M."

Phrase: ","

Phrase: "Hevi,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Chuck,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.372: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.373: (2003) Am. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.374: J. 

Phrase: "J."
Processing 00000000.tx.375: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.376: Cell Physiol. 

Phrase: "Cell Physiol."
Processing 00000000.tx.377: 284, C1272C1279[Abstract/Free FullText] Liu, Y., and Min, W. 

Phrase: "284,"

Phrase: "C1272C1279"

Phrase: "[Abstract/Free FullText"

Phrase: "] Liu,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0702093:/min [Temporal Concept]

Phrase: "W."
Processing 00000000.tx.378: (2002) Circ. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Circ."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332520:Circ [Quantitative Concept]
  1000   C2347774:circ [Quantitative Concept]
Processing 00000000.tx.379: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.380: 90, 12591266[Abstract/Free FullText] Spyrou, G., Enmark, E., Miranda-Vizuete, A., and Gustafsson, J. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "12591266"

Phrase: "[Abstract/Free FullText"

Phrase: "] Spyrou,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Enmark,"

Phrase: "E.,"

Phrase: "Miranda-Vizuete,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Gustafsson,"

Phrase: "J."
Processing 00000000.tx.381: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.382: Biol. 

Phrase: "Biol."
Processing 00000000.tx.383: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.384: 272, 29362941[Abstract/Free FullText] Zou, M. 

Phrase: "272,"

Phrase: "29362941"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zou,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.385: H., Shi, C., and Cohen, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shi,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Cohen,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.386: A. 

Phrase: "A."
Processing 00000000.tx.387: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.388: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.389: Invest. 

Phrase: "Invest."
Processing 00000000.tx.390: 109, 817826[Abstract/Free FullText] Landmesser, U., Dikalov, S., Price, S. 

Phrase: "109,"

Phrase: "817826"

Phrase: "[Abstract/Free FullText"

Phrase: "] Landmesser,"

Phrase: "U.,"

Phrase: "Dikalov,"

Phrase: "S."

Phrase: ","

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.391: R., McCann, L., Fukai, T., Holland, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "McCann,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Fukai,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Holland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027778:Holland [Geographic Area]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.392: M., Mitch, W. 

Phrase: "M."

Phrase: ","

Phrase: "Mitch,"

Phrase: "W."
Processing 00000000.tx.393: E., and Harrison, D. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Harrison,"

Phrase: "D."
Processing 00000000.tx.394: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.395: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.396: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.397: Invest. 

Phrase: "Invest."
Processing 00000000.tx.398: 111, 12011209[Abstract/Free FullText] Ceriello, A., dello Russo, P., Amstad, P., and Cerutti, P. 

Phrase: "111,"

Phrase: "12011209"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ceriello,"

Phrase: "A.,"

Phrase: "dello Russo,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Amstad,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Cerutti,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.399: (1996) Diabetes 45, 471477[Abstract] Hink, H. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Diabetes 45,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "471477"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hink,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.400: U., Santanam, N., Dikalov, S., McCann, L., Nguyen, A. 

Phrase: "U.,"

Phrase: "Santanam,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Dikalov,"

Phrase: "S."

Phrase: ","

Phrase: "McCann,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Nguyen,"

Phrase: "A."
Processing 00000000.tx.401: D., Parthasarathy, S., Harrison, D. 

Phrase: "D."

Phrase: ","

Phrase: "Parthasarathy,"

Phrase: "S."

Phrase: ","

Phrase: "Harrison,"

Phrase: "D."
Processing 00000000.tx.402: G., and Fukai, T. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Fukai,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.403: (2002) Arterioscler. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Arterioscler."
Processing 00000000.tx.404: Thromb. 

Phrase: "Thromb."
Processing 00000000.tx.405: Vasc. 

Phrase: "Vasc."
Processing 00000000.tx.406: Biol. 

Phrase: "Biol."
Processing 00000000.tx.407: 22, 14021408[Abstract/Free FullText] Li, W. 

Phrase: "22,"

Phrase: "14021408"

Phrase: "[Abstract/Free FullText"

Phrase: "] Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "W."
Processing 00000000.tx.408: G., Miller, F. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.409: J., Jr., Zhang, H. 

Phrase: "J.,"

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Zhang,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.410: J., Spitz, D. 

Phrase: "J.,"

Phrase: "Spitz,"

Phrase: "D."
Processing 00000000.tx.411: R., Oberley, L. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Oberley,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.412: W., and Weintraub, N. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Weintraub,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.413: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.414: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.415: Biol. 

Phrase: "Biol."
Processing 00000000.tx.416: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.417: 276, 2925129256[Abstract/Free FullText] Du, K., Herzig, S., Kulkarni, R. 

Phrase: "276,"

Phrase: "2925129256"

Phrase: "[Abstract/Free FullText"

Phrase: "] Du,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540681:DU [Idea or Concept]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Herzig,"

Phrase: "S."

Phrase: ","

Phrase: "Kulkarni,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.418: N., and Montminy, M. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Montminy,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.419: (2003) Science 300, 15741577[Abstract/Free FullText] Hirota, T., Okano, T., Kokame, K., Shirotani-Ikejima, H., Miyata, T., and Fukada, Y. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Science 300,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "15741577"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hirota,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Okano,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kokame,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Shirotani-Ikejima,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Miyata,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Fukada,"

Phrase: "Y."
Processing 00000000.tx.420: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.421: Biol. 

Phrase: "Biol."
Processing 00000000.tx.422: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.423: 277, 4424444251[Abstract/Free FullText] Shalev, A., Pise-Masison, C. 

Phrase: "277,"

Phrase: "4424444251"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shalev,"

Phrase: "A.,"

Phrase: "Pise-Masison,"

Phrase: "C."
Processing 00000000.tx.424: A., Radonovich, M., Hoffmann, S. 

Phrase: "A.,"

Phrase: "Radonovich,"

Phrase: "M."

Phrase: ","

Phrase: "Hoffmann,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.425: C., Hirshberg, B., Brady, J. 

Phrase: "C., Hirshberg,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Brady,"

Phrase: "J."
Processing 00000000.tx.426: N., and Harlan, D. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Harlan,"

Phrase: "D."
Processing 00000000.tx.427: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.428: (2002) Endocrinology 143, 36953698[Abstract/Free FullText] Kobayashi, T., Uehara, S., Ikeda, T., Itadani, H., and Kotani, H. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Endocrinology 143,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: "36953698"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kobayashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Uehara,"

Phrase: "S."

Phrase: ","

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Itadani,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Kotani,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.429: (2003) Kidney Int. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Kidney Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063789:INT [Organic Chemical]
   861   C3272375:INT [Intellectual Product]
Processing 00000000.tx.430: 64, 16321642[CrossRef][Medline] [OrderarticleviaInfotrieve]

Phrase: "64,"

Phrase: "16321642"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

